Localization of a Microsporidia ADAM (A Disintegrin and Metalloprotease Domain) Protein and Identification of Potential Binding Partners. by Jolly, Carrie E.
East Tennessee State University
Digital Commons @ East
Tennessee State University
Electronic Theses and Dissertations Student Works
12-2007
Localization of a Microsporidia ADAM (A
Disintegrin and Metalloprotease Domain) Protein
and Identification of Potential Binding Partners.
Carrie E. Jolly
East Tennessee State University
Follow this and additional works at: https://dc.etsu.edu/etd
Part of the Amino Acids, Peptides, and Proteins Commons
This Dissertation - Open Access is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State
University. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital Commons @ East
Tennessee State University. For more information, please contact digilib@etsu.edu.
Recommended Citation
Jolly, Carrie E., "Localization of a Microsporidia ADAM (A Disintegrin and Metalloprotease Domain) Protein and Identification of
Potential Binding Partners." (2007). Electronic Theses and Dissertations. Paper 2052. https://dc.etsu.edu/etd/2052
Localization of a Microsporidia ADAM (a Disintegrin and Metalloprotease Domain) Protein 
and Identification of Potential Binding Partners 
 
 
 
 
A dissertation 
presented to 
the faculty of the Department of Microbiology 
East Tennessee State University 
 
In partial fulfillment 
of the requirements for the degree 
Doctor of Philosophy in Biomedical Sciences 
 
 
 
 
by 
Carrie E. Jolly 
December 2007 
 
 
 
 
J. Russell Hayman, Ph.D., Chair 
Robert V. Schoborg, Ph.D. 
David A. Johnson, Ph.D. 
Jane E. Raulston, Ph.D. 
Michelle M. Duffourc, Ph.D. 
John J. Laffan, Ph.D. 
 
Keywords:  Microsporidia, Encephalitozoon intestinalis, Encephalitozoon cuniculi, ADAM, 
Yeast Two-Hybrid, Polar Tube Protein 
 2 
ABSTRACT 
 
Localization of a Microsporidia ADAM (a Disintegrin and Metalloprotease Domain) Protein 
and Identification of Potential Binding Partners 
 
by 
 
Carrie E. Jolly 
 
Microsporidia are spore-forming, obligate intracellular pathogens typically associated with 
opportunistic infections in immunocompromised individuals.  Treatment options for 
microsporidia infections in humans are limited and additional research is necessary to 
create better therapeutic agents.  For many pathogenic organisms, adhesion to the host cell 
surface is a prerequisite for tissue colonization and invasion.  Our previous research has 
demonstrated a direct relationship between adherence of microsporidia spores to the 
surface of host cells and infectivity in vitro.  In an effort to better understand adherence, we 
have turned our attention to determining what proteins may be involved in this process.  
Examination of the Encephalitozoon cuniculi genome database revealed a gene encoding a 
protein with sequence homology to members of the ADAM (a disintegrin and 
metalloprotease) family of type I transmembrane glycoproteins.  The microsporidia ADAM 
(MADAM) protein is of interest because ADAMs are known to be involved in a variety of 
biological processes including cell adhesion, proteolysis, cell fusion, and signaling.  The 
objectives for this study were to examine the localization of MADAM, analyze its potential 
involvement during adherence and/or host cell infection, and to identify potential binding 
partners or substrates.  Through the use of immunoelectron transmission microscopy, we 
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demonstrated that MADAM is localized to the surface exposed exospore, plasma membrane, 
and the polar sac-anchoring disk complex (a bell-shaped structure at the spore apex 
involved in the infection process).  Location of MADAM within the exospore and polar sac-
anchoring disk suggests that MADAM is in a position to facilitate spore adherence or host 
cell infection.  Thus far, we have been unable to conclusively demonstrate that MADAM is 
involved in either event.  Through the use of a yeast two-hybrid system, we were able to 
identify polar tube protein 3 (PTP3) as a potential binding partner or substrate for the 
MADAM protein.  The interaction between MADAM and PTP3 was confirmed by in vitro co-
immunoprecipitation.  PTP3 is hypothesized to be involved in the process of polar tube 
extrusion by stabilizing the interaction between PTP1-PTP2 polymers.  Further analysis of the 
interaction between MADAM and PTP3 may lead to a better understanding of the events 
that occur during polar tube extrusion.     
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CHAPTER 1 
INTRODUCTION 
 
Microsporidia Infection in Humans 
 Microsporidia are spore-forming, obligate intracellular, fungal-related pathogens with 
a diverse host range that includes most vertebrates and invertebrates.  Traditionally, 
microsporidiosis was considered an economically devastating disease of insects (silkworm 
and honeybee), fish, and fur-bearing mammals (mink, laboratory rabbits, and rodents)  
(Didier and others 2004).  Today, microsporidia are recognized as an emerging and 
opportunistic pathogen of humans, particularly those infected with the human 
immunodeficiency virus (HIV) (Didier and Weiss 2006).  In addition to individuals with HIV, 
microsporidia infections have been documented in an assortment of human populations 
including travelers, contact lens wearers, malnourished children, organ transplant 
recipients, and the elderly (Deplazes and others 2000; Didier and others 2004).  
Only 14 of the estimated 1,200 species of microsporidia are known to infect humans 
(Didier and others 2004).  Enterocytozoon bieneusi and Encephalitozoon intestinalis are the 
most frequently diagnosed causes of human microsporidiosis (Mathis and others 2005).  
Most cases of microsporidia infection are thought to occur through ingestion of the 
environmentally stable spores, which results in a primary infection of the small intestine 
epithelium (Didier and Weiss 2006).  Exact sources of microsporidia infection in humans 
and possible routes of transmission remain largely undetermined.  However, microsporidia 
known to infect humans have been identified in domestic and wild animals, which supports 
the hypothesis that microsporidiosis is a zoonotic disease (Didier and Weiss 2006).  
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The most common clinical manifestations of microsporidiosis are self-limiting 
diarrhea in immunocompetent individuals and severe persistent diarrhea in the 
immunocompromised (Didier and others 2004).  Severe, persistent diarrhea in 
immunocompromised individuals is often accompanied by fever, appetite loss, weight loss, 
and wasting syndrome (Didier and others 2004).  Encephalitozoon species cause 
disseminated infections with a number of serious clinical manifestations including myositis, 
encephalitis, sinusitis, pneumonia, hepatitis, and peritonitis (Didier and Weiss 2006).  The 
clinical manifestations of microsporidia infection are determined by a number of factors 
including immune status of the host, the location of infection, and which species is 
responsible for the infection.  
Human microsporidial infections are most often treated with either albendazole or 
fumagillin (Didier and Weiss 2006).  Albendazole, an anti-mitotic agent due to its ability to 
disrupt tubulin polymerization, stops mitosis in both the microsporidia and the host cell 
(Conteas and others 2000).  Short-term albendazole therapy does not result in clearance of 
the infection but rather prevents the microsporidia from spreading.  Although albendazole is 
successful at treating microsporidiosis due to Encephalitozoon species, it is not an effective 
treatment against the most common cause of human microsporidiosis, Enterocytozoon 
bieneusi (Conteas and others 2000).  Fumagillin, an antibiotic produced by the fungus 
Asperigillus fumigatus, selectively inhibits the activity of methionine aminopeptidase 2 
(MetAP2) from the host cell and developing microsporidia (Upadhya and others 2006).  
Fumagillin can be used to successfully treat gastrointestinal infections attributed to 
Enterocytozoon bieneusi as well as ocular infections due to Encephalitozoon species 
(Conteas and others 2000).  Unfortunately, patients often develop thrombocytopenia and 
neutropenia that resolve after cessation of fumagillin therapy (Conteas and others 2000).  
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Treatment options for microsporidia infections in humans are limited and additional 
research is necessary to create better therapeutic agents or to manage the side effects of 
current treatments. 
 
Microsporidia Spore Structure and Development 
 Mature spores are the environmentally resistant, infectious stage of microsporidial 
development (Bigliardi and Sacchi 2001).  Environmental stability is provided by a rigid 
spore wall that consists of an outer electron-dense exospore composed of proteinaceous 
material, an electron-lucent endospore composed of protein and chitin or a chitin-like 
material, and an inner plasma membrane (Bigliardi and Sacchi 2001).  Mature 
microsporidia spores contain several characteristic structures including a lamellar 
polaroplast, posterior vacuole, anchoring disk, and an organelle unique to the phylum 
Microspora called the polar filament or polar tube (Figure 1).  The polar tube arises from an 
anchoring disk in the anterior region then coils around the infectious sporoplasm in the 
posterior region of the mature spore.  Microsporidia are considered eukaryotes mainly 
because they possess a nucleus but also resemble prokaryotic organisms as they lack 
mitochondria, peroxisomes, and a typical Golgi apparatus (Bigliardi and Sacchi 2001). 
As stated previously, the majority of microsporidia infections are thought to occur via 
ingestion of the environmentally stable spores, which results in a primary infection of the 
small intestine epithelium.  Traditionally, microsporidia were believed to infect a host cell by 
extruding the polar tube at a velocity fast enough to pierce the host cell plasma membrane 
thereby allowing the infectious sporoplasm to pass through the hollow polar tube and into 
the host cell cytoplasm (Vivares and Metenier 2001).  Once within the host cell cytoplasm, 
the infectious sporoplasm undergoes a phase of proliferative growth by nuclear division 
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known as merogony (Bigliardi and Sacchi 2001).  Meronts, which consist of a simple plasma 
membrane and sparse organelles, transition into sporonts that are characterized by the 
appearance of an electron-dense material along the outer membrane (Figure 1).  Sporonts 
mature into sporoblasts following additional development of the organelles.  Sporoblasts are 
the final phase before the appearance of mature spores with fully formed and properly 
oriented organelles (Figure 1).  
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Figure 1 Ultrastructure of Encephalitozoon intestinalis within Vero E6 host cells. (A) Mature 
E. intestinalis spores (S) and other developmental stages including meronts (M), sporonts 
(ST), and sporoblasts (SB) are observed developing within several parasitophorous vacuoles 
(PV). Note the host cell nucleus (N) compressed to the periphery. (B) Structures within the 
mature spore include the nucleus (NU), lamellar polaroplast (PL), polar tube (PT), polar sac 
(PS), and an anchoring disc (AD). (C) A mature E. intestinalis spore demonstrating the 
electron-dense exospore (EX), an inner electron-lucent endospore (EN), and the polar tube 
with 4 or 5 coils (∗) around the posterior region. (adapted from Croppo and others 1998). 
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Each stage of microsporidia development can be observed simultaneously within an 
infected host cell (Figure 1).  Encephalitozoon species are segregated within a compartment 
known as the parasitophorous vacuole while other species such as Enterocytozoon bieneusi 
develop in direct contact with the host cell cytoplasm.  A host cell will support microsporidia 
development for several days before rupture of the host cell plasma membrane and the 
parasitophorous vacuole resulting in the release of mature spores into the extracellular 
environment.  Exactly how a host cell can support microsporidia development without 
apparent detriment for several days remains to be determined.  It has been suggested that 
microsporidia manipulate the host cell cycle and/or apoptotic pathways during development 
(Scanlon and others 2000; del Aguila and others 2006).   
 
Microsporidia Spore Activation and Polar Tube Discharge 
 Although many of the details regarding how polar tube extrusion leads to host cell 
infection are still undetermined, the following series of events are thought to be involved: 1) 
activation of the spore, 2) increase in internal osmotic pressure, 3) discharge of the polar 
tube, and 4) passage of the infectious sporoplasm through the polar tube and into the host 
cell cytoplasm (Xu and Weiss 2005).  Numerous stimuli have been reported to induce polar 
tube discharge including changes in pH, addition of various cations and anions, dehydration 
followed by rehydration, and hydrogen peroxide (Xu and Weiss 2005).  Each stimulus 
studied thus far appears to elicit an increase in osmotic pressure inside the spore followed 
by an influx of water and swelling of the polaroplast (Bigliardi and Sacchi 2001).   
As the polaroplast swells, the anchoring disk protrudes to form a collar-like structure 
that serves to hold the polar tube in place during discharge (Figure 2).  As the polar tube 
emerges from the spore apex, it is thought to either 1) exit at a high velocity allowing it to 
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pierce the host cell plasma membrane like a hypodermic needle or 2) enters the host cell by 
a phagocytic process brought about by an interaction between the spore apex and the host 
cell surface (Xu and Weiss 2005).  As the posterior vacuole begins to swell, pressure forces 
the infectious sporoplasm through the polar tube into the host cell cytoplasm (Bigliardi and 
Sacchi 2001). 
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Figure 2 Phases of polar tube discharge in Encephalitozoon hellem. (A) At the beginning of 
polar tube discharge, the polar tube (PT) protrudes from the spore apex at the polar cap (PC) 
or anchoring disk region. (B) As polar tube discharge continues, the anchoring disk (AD) 
forms a collar-like structure and the posterior vacuole (V) enlarges in order to force the 
infectious sporoplasm through the polar tube. (C) Once inside the host cell cytoplasm, the 
infectious sporoplasm (S) can be seen surrounded by host cell mitochondria (M). (D) In this 
electron micrograph, the polar tube (PT) appears to be enclosed within an invagination of 
the host cell membrane (arrow heads). (adapted from Bigliardi and Sacchi 2001). 
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Microsporidia Spore Adherence to the Host Cell Surface 
 Adhesion to the host cell surface is a prerequisite to tissue colonization and invasion 
for many pathogenic organisms.  During in vitro propagation, microsporidia spores can be 
observed adhering to host cells and routine washing does not remove these attached spores 
(Hayman and others 2005).  We hypothesize that adherence of microsporidia spores to the 
host cell surface is an event that may trigger polar tube extrusion and subsequent host cell 
infection.  Numerous organisms including bacteria, viruses, and parasites exploit host cell 
glycosaminoglycans as adhesion receptors (Rostand and Esko 1997).  In fact, we have 
demonstrated that in an in vitro system E. intestinalis spores adhere to the host cell surface 
through at least one mechanism involving sulfated glycosaminoglycans (Hayman and others 
2005).   
Glycosaminoglycans are unbranched polysaccharide chains linked to transmembrane 
proteins expressed on the surface of nearly all mammalian cells (Hallak and others 2000).  
Some glycosaminoglycans, including heparin sulfate and chondroitin sulfate A (CSA), are 
sulfated and therefore possess an overall negative charge (Hallak and others 2000).  We 
found that addition of sulfated glycosaminoglycans, like CSA, to the tissue culture medium 
results in a decrease in E. intestinalis spore adherence to the host cell surface and a 
decrease in the percentage of infected host cells (Figure 3) (Hayman and others 2005).  A 
separate group of researchers found similar results during their investigation of E. 
intestinalis spore phagocytosis by differentiated intestinal epithelial cells (Leitch and others 
2005).   
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To further characterize the factors involved in microsporidia adherence the role of 
divalent cations was examined.  Divalent cations are known effectors of numerous host-
pathogen interactions (Anzinger and others 2006; Southern and others 2006).  Addition of 
exogenous manganese and magnesium to the tissue culture medium resulted in an increase 
in adherence of microsporidia spores to the host cell monolayer and a subsequent increase 
in host cell infection (Southern and others 2006).  Interestingly, calcium did not contribute 
to an increase in microsporidia adherence but did lead to an increase in host cell infection 
(Southern and others 2006).  Calcium, which is known to play a role in the swelling of the 
polaroplast during polar tube extrusion, is hypothesized to actually increase the occurrence 
of polar tube extrusion and subsequent host cell infection in our in vitro system.  In the 
Figure 3 Effect of inhibition of E. intestinalis spore adherence on host cell infection. Vero 
host cell monolayers were incubated with E. intestinalis spores in the presence or absence 
of chondroitin sulfate A (CSA). Following an incubation period, each coverslip was washed to 
remove unbound spores. One set of coverslips were processed to determine the amount of 
adherence inhibition (A) while the remaining coverslips were returned to culture for later 
analysis of infected host cells (B). Addition of CSA to the tissue culture medium resulted in a 
72% decrease in E. intestinalis spore adherence as compared to the control (A) and a 68-
78% decrease in infectivity depending on the quantity of E. intestinalis spores (B). (adapted 
from Hayman and others 2005). 
A. B. 
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presence of chelating agents, we were able to eliminate the augmentation of microsporidia 
spore adherence and host cell infection by the divalent cations (Southern and others 2006). 
  Like many other pathogenic intracellular organisms, microsporidia appear to use 
adherence to the host cell surface as a mechanism to facilitate invasion.  In an effort to 
better understand the mechanism of microsporidia spore adherence, we have turned our 
attention to determining what microsporidia proteins may be involved in this process.  
Identification of microsporidia ligands and host cell receptors that mediate adherence of the 
spore to the host cell surface may lead to the development of novel therapies aimed at 
preventing infection.  
 
The Microsporidia ADAM Protein 
To identify microsporidia proteins potentially involved in adherence, the 
Encephalitozoon cuniculi genome database was searched for genes that encode proteins 
with recognizable adhesion domains.  This examination revealed a protein (CAD25398) with 
sequence homology to members of the ADAM (a disintegrin and metalloprotease domain) 
family.  ADAMs have been described in a diverse group of organisms including mammals 
(i.e. Homo sapiens and Mus musculus), insects (i.e. Drosophila and Apis), purple sea 
urchins (Strongylocentrotus purpuratus), frogs (Xenopus), and fungi (S. pombe) (Rise and 
Burke 2002).   ADAMs are a group of type I transmembrane glycoproteins involved in a 
variety of biological processes including cell adhesion, proteolysis, cell fusion, and signaling 
(White 2003).  For example, ADAM10 has been implicated in the process of tumor cell 
metastasis through at least one mechanism involving cleavage of the cellular adhesion 
molecule, E-cadherin (Reiss and others 2006).  Initial studies on the potential role of ADAMs 
in pathogenesis of human disease has revealed an association of several ADAMs with 
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diseases such as rheumatoid arthritis, Crohn’s disease, diabetes, Alzheimer’s, cancer, 
asthma, and microbial infections (Tousseyn and others 2006).    
The theoretical molecular weight and isoelectric point of this microsporidia ADAM 
protein (MADAM) are predicted to be 61kDa and 5.80, respectively.  Analysis of MADAM 
using the Conserved Domain Database revealed motifs in the sequence similar to those 
found in the snake venom disintegrins (E-value = 4e-13) and zinc-dependent 
metalloproteases (E-value = 1e-5), which includes the ADAM family (Marchler-Bauer and 
Bryant 2004).  Most ADAMs share a common multi-domain organization consisting of a 
signal sequence, a pro-domain, a metalloprotease domain, a disintegrin-like domain, a 
cysteine-rich domain, an epidermal growth factor (EGF)-like domain, and a transmembrane 
domain followed by a cytoplasmic tail (White 2003).  Like other ADAMs, MADAM has a 
predicted signal sequence, pro-domain, metalloprotease domain, disintegrin-like domain, 
and a transmembrane domain (Figure 4).  In contrast to other ADAMs, MADAM lacks a 
recognizable cysteine-rich domain, an EGF-like domain, and a cytoplasmic tail but does have 
a region without homology to any identified proteins located between the disintegrin and 
transmembrane domains (Figure 4).      
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Figure 4 Predicted MADAM domain structure compared to the consensus ADAM domains. 
MADAM lacks a predicted cysteine-rich domain, an EGF-like domain, and a cytoplasmic tail 
but instead possesses a region of unknown homology between the disintegrin and 
transmembrane domains. 
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The N-terminal region consists of a signal sequence that is responsible for directing 
ADAMs into the secretory pathway and the pro-domain that functions in maturation of the 
protein (Seals and Courtneidge 2003).  In many cases, the pro-domain maintains the 
metalloprotease domain in an inactive conformation by using what is known as a cysteine-
switch mechanism (Tousseyn and others 2006).  In the cysteine-switch mechanism, an 
unpaired cysteine residue located in the pro-domain preferentially coordinates the zinc atom 
required within the zinc-dependent catalytic site of the metalloprotease domain (Seals and 
Courtneidge 2003).  While several ADAMs contain an odd number of cysteine residues 
within their sequence, MADAM contains an even number of closely spaced cysteine residues 
which suggests that MADAM may not use the cysteine-switch mechanism.  In order for the 
metalloprotease domain to become active, a conformational change must occur by 
proteolytic or autocatalytic removal of the pro-domain.  Furin, a pro-protein convertase, is 
known to cleave the pro-domain of ADAMs at the conserved recognition sequence, Rx(R/K)R 
(Tousseyn and others 2006).  MADAM does not have a recognizable pro-protein convertase 
recognition sequence within its pro-domain.  Therefore, MADAM pro-domain removal may 
occur through cleavage by an unidentified microsporidia or host protease or by an 
autocatalytic mechanism as is the case for ADAM8 and ADAM28 (Seals and Courtneidge 
2003).   
 MADAM is predicted to belong to a large superfamily of proteases known as the 
metzincin family, which includes ADAM, ADAMTS, BMP1/TLL, meprin, and matrix 
metalloproteases (Huxley-Jones and others 2007).  Members of the metzincin superfamily 
are characterized by the presence of a conserved zinc-dependent catalytic site sequence as 
well as a conserved methionine residue known as the ‘Met-Turn’, which appears to be 
essential in maintaining integrity of the zinc binding site (Stocker and others 1995).  Of the 
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38+ known ADAM proteins, at least 26 contain the conserved zinc-dependent catalytic site 
sequence (HExxHxxGxxH) within their metalloprotease domain and are predicted to be 
catalytically active (White 2003) and (http://www.people.virginia.edu/~jw7g/Table_of_the_ 
ADAMs.html).  Based on global pairwise alignment, MADAM does appear to possess the 
conserved zinc-dependent catalytic site sequence and a ‘Met-Turn’ (Figure 5).  
 
  
 
 
 
 
 
 
 
 
Disintegrin domains were originally described as the component of snake venom 
metalloproteases responsible for preventing platelet aggregation by binding to platelet 
integrins (Seals and Courtneidge 2003).  Many of the snake venom metalloproteases have 
an RGD consensus motif within their disintegrin domain that mediates binding to integrins 
(Seals and Courtneidge 2003).  Of the 38+ known ADAMs, human ADAM15 is the only one 
that has an RGD sequence in the disintegrin domain (Seals and Courtneidge 2003).  Several 
other ADAMs, excluding ADAM10 and ADAM17, bind the integrin α9β1 via a conserved 
sequence, Rx6DLPEF, located in the disintegrin domain (Eto and others 2002).  Global 
pairwise alignment of the MADAM disintegrin domain with other ADAMs demonstrates that 
sequence identities range from 33% for ADAM10 to 41% for ADAM9.  This high level of 
identity is due in part to the presence of 14 conserved cysteine residues within the MADAM 
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Figure 5 Global pairwise alignment of metalloprotease active site sequences from MADAM 
and several other ADAM family members. The metalloprotease active site from MADAM 
contains the conserved zinc-dependent catalytic site sequence (HExxHxxGxxH) and ‘Met-
Turn’ (CIM) that are indicative of metallo-proteases from the metzincin family. Like other 
ADAMs that possess this conserved metallo-protease domain, MADAM is predicted to be 
catalytically active.   
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disintegrin domain, which suggests that MADAM may have a secondary structure and 
function similar to other ADAMs (Figure 6).  Interestingly, MADAM contains a five amino acid 
insertion, NIHKM, within the area considered to be the integrin-binding region of the 
disintegrin domain (Figure 6). 
Figure 6 Global pairwise alignment of disintegrin domain sequences from MADAM and 
several other ADAM family members. MADAM has high sequence similarity to other ADAMs 
due in part to conservation of several cysteine residues. The region responsible for integrin 
binding is marked with an arrow (     ). The conserved sequence, Rx6DLPEF, has been shown 
to be essential for binding of several ADAMs (excluding ADAM10 and ADAM17) to the 
integrin α9β1. MADAM contains a five amino acid insertion (NIHKM) with unknown 
significance within the integrin-binding region. 
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Specific Aims 
 
As stated previously, little is known regarding how microsporidia invade host cells 
other than that polar tube extrusion must occur.  Based on previous research, we 
hypothesize that adherence of microsporidia spores to the host cell surface is an event that 
may trigger polar tube extrusion and subsequent host cell infection.  In an effort to better 
understand the mechanism of microsporidia spore adherence, we have turned our attention 
to determining what microsporidia proteins may be involved in this process.  MADAM is a 
protein of interest given that it shares sequence homology with members of the ADAM 
family.  ADAMs are involved in a variety of biological processes such as cell adhesion, 
proteolysis, cell fusion, and signaling.  Ultimately, we would like to determine if MADAM is 
involved in microsporidia spore adherence and/or host cell infection and if so, what role 
does it play.   
Our first objective is to determine the location of MADAM within the microsporidia 
spore by using immunoelectron microscopy.  Localization of MADAM on the surface of the 
spore or in areas such as the anchoring-disk or polar tube would suggest that MADAM may 
be in a position to facilitate microsporidia adherence or polar tube extrusion.  For our second 
objective we will use an already established in vitro system in order to assay if MADAM is 
involved in microsporidia adherence to the host cell and/or host cell infection.  Our third 
objective is to identify potential substrates or binding partners for MADAM using a yeast two-
hybrid approach.  By completing these objectives, we should be able to develop a hypothesis 
regarding the potential role of MADAM within the microsporidia.  
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CHAPTER 2 
MATERIALS AND METHODS 
 
Microsporidia Spore Propagation and Purification 
E. cuniculi and E. intestinalis were propagated in rabbit kidney cells (RK-13; ATCC 
CCL-37) or African green monkey kidney cells (Vero; ATCC CCl-81) as previously described 
(Hayman and Nash 1999).  Briefly, subconfluent RK-13 or Vero monolayers grown in 75-cm2 
tissue culture flasks were incubated with either E. cuniculi or E. intestinalis spores for 10-12 
days with growth medium replacement as needed.  Cultures were maintained in 5% CO2 at 
37°C with growth medium consisting of Dulbecco’s modified Eagle’s medium (BioWhittaker; 
Walkersville, MD) supplemented with L-glutamine (2mM), penicillin (100U/ml), streptomycin 
(100μg/ml), amphotericin B (0.25μg/ml), and 2% fetal bovine serum (FBS).  Spores were 
harvested by centrifugation at 3,500 RPM for 10 minutes and purified from the host cell 
debris by washing with 0.25% sodium dodecyl sulfate (SDS) followed by several washes in 
sterile water.  Spores were counted and stored in sterile water at 4°C. 
 
Cloning and Recombinant Expression of the E. cuniculi MADAM Protein 
DNA encoding the region from the pro-domain to the transmembrane-domain or 
amino acids 21-527 of MADAM was amplified by PCR using genomic DNA from E. cuniculi 
infected RK-13 cells as the template and the following oligonucleotide primers: DIS-F1-E; 5’-
GGAATTCTTCACTGACCCGGATGGTAAG-3’ and DIS-R1-X; 5’-ACTCGAGTGTAGCTGCTGAATTGCTG 
TCTC-3’.  The resulting PCR product was digested with EcoRI and XhoI then ligated into the 
linearized pET-21a vector (EMD Chemicals, Inc.; San Diego, CA) to generate the pET-
21a+MADAM (∆SS/∆TM) plasmid.  Escherichia coli XLI-Blue (Stratagene; La Jolla, CA) was 
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used as the host strain for plasmid propagation.  After verifying the DNA sequence, the pET-
21a+MADAM (∆SS/∆TM) plasmid was transformed into E. coli Rosetta-gami cells (EMD 
Chemicals, Inc.; San Diego, CA) for protein expression.  Recombinant protein expression was 
induced at an OD600 of approximately 0.6 by the addition of 1mM isopropyl-ß-D-
thiogalactopyranoside (IPTG) to the culture for 4 hours at 37°C with shaking.  After 
induction, the bacteria were harvested, resuspended in binding buffer (1X phosphate buffer 
pH 7.4, 20mM Imidazole, and 8M urea), and lysed by sonication. 
Protein lysate from induced and non-induced bacteria cultures was separated by 
sodium lauryl dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).  Proteins were 
then stained with Coomassie Brilliant Blue R (Sigma-Aldrich; St. Louis, MO) or transferred to 
nitrocellulose membrane for Western analysis.  Following the transfer, the membrane was 
blocked with 5% non-fat dry milk in 1X Tris buffered saline (TBS) pH 7.4 for 30 minutes.  The 
membrane was then incubated for 1 hour in a 1:1,000 dilution of mouse monoclonal anti-
polyhistidine antibody (Sigma-Aldrich; St. Louis, MO) prepared in TBS plus 0.05% Tween-20 
(1X TBST) followed with a 1:2,000 dilution of rabbit anti-mouse alkaline phosphatase-
conjugated antibody (Southern Biotech; Birmingham, AL) also prepared in 1X TBST.  
Colorimetric detection was performed using a combination of BCIP (5-bromo-4-chloro-3'-
indolyphosphate p-toluidine salt) and NBT (nitro-blue tetrazolium chloride) (Pierce; Rockford, 
IL). 
 
Purification of the Histidine-Tagged Recombinant MADAM Protein and Antibody Production 
Purification of the rMADAM-His·Tag protein from E. coli was performed according to 
the manufacturer’s protocol for the HiTrap HP Kit (GE Healthcare; Piscataway, NJ).  Elution 
fractions containing rMADAM-His·Tag protein were combined, dialyzed overnight against 
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10mM Tris-HCl pH 7.5, and concentrated in a Centriplus centrifugal filter device (Millipore; 
Billerica, MA).  Purified rMADAM-His·Tag protein was sent to Proteintech Group, Inc. (Chicago, 
IL) for polyclonal antibody production in two pre-screened rabbits.  Following the 56-day 
antibody production protocol, total IgG antibodies were purified from the rabbit pre-bleed 
and final bleed sera according to the manufacturer’s protocol for Immobilized Protein A/G 
Agarose (Pierce; Rockford, IL). 
 
Western Analysis of E. cuniculi and E. intestinalis Spore Protein 
Total protein was extracted from E. cuniculi and E. intestinalis spores by boiling for 
15-30 minutes in the presence of lysis buffer (5% SDS, 60mM Tris-HCl pH 6.8, 10% glycerol) 
with fresh 2-mercaptoethanol (2-ME) added to a final concentration of 15% (v/v).  After 
centrifugation at 13,000 RPM for 5 minutes to remove spore debris, the resulting protein 
lysate was separated by SDS-PAGE.  For Western analysis, membranes were incubated in a 
1:500 dilution of the anti-rMADAM-His·Tag antibody prepared in 1X TBST followed with a 
1:2,000 dilution of goat anti-rabbit alkaline phosphatase-conjugated antibody (Southern 
Biotech; Birmingham, AL) also prepared in 1X TBST.  Colorimetric detection was performed 
using a combination of BCIP and NBT.    
 
Identification of the ~143kDa E. cuniculi Spore Protein 
A sheet of nitrocellulose membrane was incubated for 1 hour with a 1:100 dilution of 
anti-rMADAM-His·Tag antibody prepared in 1X TBST.  After blocking the membrane with 5% 
non-fat dry milk in 1X TBS, the membrane was incubated overnight in a solution of protein 
lysate extracted from E. cuniculi spores.  Unbound E. cuniculi proteins were removed by 
washing in 1X TBST then the remaining E. cuniculi proteins were eluted in the presence of 
 29 
lysis buffer (5% SDS, 60mM Tris-HCl pH 6.8, 10% glycerol) with fresh 2-ME added to a final 
concentration of 15% (v/v).  The resulting protein sample, which represented E. cuniculi 
protein that specifically bound to anti-rMADAM-His·Tag antibody, was separated by SDS-
PAGE.  For Western analysis, membranes were incubated in a 1:500 dilution of the anti-
rMADAM-His·Tag antibody prepared in TBST followed by a 1:2,000 dilution of goat anti-rabbit 
alkaline phosphatase-conjugated antibody (Southern Biotech; Birmingham, AL) also 
prepared in TBST.  Colorimetric detection was performed using a combination of BCIP and 
NBT.  The E. cuniculi protein band located at ~143kDa on the Coomassie stained gel was 
excised and sent to Midwest Bio Services, LLC (Overland Park, KS) for mass spectrometry 
analysis. 
 
Immunolabeling and Transmission Electron Microscopy 
RK-13 monolayers grown in T-75 cm2 flasks were incubated with E. cuniculi or E. 
intestinalis spores until numerous infected foci could be observed.  Infected RK-13 
monolayers were fixed for 1 hour with 2% paraformaldehyde plus 0.05% glutaraldehyde in 
0.2M Sorenson’s buffer.  Following several washes with 0.1M Sorenson’s buffer, the 
monolayers were removed by scraping and enrobed in 3% SeaKem agar.  The agar enrobed 
pellet was washed 3 times with 0.1M Sorenson’s buffer at 4°C for 15 minutes.  The pellet 
was sequentially dehydrated with 35% methanol, 50% methanol, 70% methanol at 4°C for 5 
minutes and with 90% methanol at -20°C for 30 minutes.  The following infiltration steps 
were performed for 1 hour at -20°C: 1:1 Lowicryl K4M resin/90% methanol, 2:1 Lowicryl 
K4M resin/90% methanol, and Lowicryl K4M resin only.  The pellet was incubated in 
Lowicryl K4M resin overnight at -20°C.  The pellet was then embedded in Lowicryl K4M resin 
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and photo-polymerization was carried out for 2 days at -20°C, 2 days at 4°C, and at room 
temperature for 2 days. 
All solutions for immunolabeling were filter sterilized immediately prior to use.  Gold 
thin sections were incubated in a blocking solution containing 1% albumin and 0.01M 
glycine prepared in phosphate buffered saline (PBS) for 5 minutes.  The gold thin sections 
were then incubated with various dilutions of Protein A/G purified polyclonal rabbit antibody 
against the rMADAM-His·Tag protein prepared in blocking solution for 40 minutes at 37°C 
and washed with PBS three times for 5 minutes each.  The gold thin sections were blocked 
again for 5 minutes then incubated for 30 minutes at 37°C with a 1:200 dilution of 
AuroProbe EM 15nm gold-labeled goat anti-rabbit IgG (H+L) (GE Healthcare; Piscataway, NJ).  
The gold thin sections were washed with PBS three times for 5 minutes followed by three 
fifteen minute washes with sterile water.  The gold thin sections were counterstained with 
5% uranyl acetate, washed with sterile water, and examined using a Tecnai 10 (FEI) 
transmission electron microscope.  
 
Cloning, Recombinant Expression, and Purification of E. cuniculi MADAM Deletion Mutants 
Primers were designed to PCR amplify the MADAM pro-domain (DIS-F1-E; 5’-GGAATTC 
TTCACTGACCCGGATGGTAAG-3’ and DIS-R2-X; 5’-GTACTCGAGGACGTTTCCCTCCTCATC-3’) and 
the MADAM metalloprotease-domain (DIS-F3-E; 5’-GGAATTCACAAGAGTCATCAAAGTG-3’ and 
DIS-R3-X; 5’-GTACTCGAGTATCTCGCCAAATTTGGATTC-3’).  Each PCR product was digested 
with EcoRI and XhoI then ligated into the pET-21a vector (EMD Chemicals, Inc.; San Diego, 
CA) to create the pET-21a+PRO and pET-21a+MET plasmids.  E. coli XLI-Blue (Stratagene; La 
Jolla, CA) was used as the host strain for plasmid propagation.  After verifying the DNA 
sequence, the pET-21a+PRO and pET-21a+MET plasmids were transformed into E. coli 
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Rosetta-gami cells (EMD Chemicals, Inc.; San Diego, CA).  Protein expression was induced at 
an OD600 of approximately 0.6 by the addition of 1mM IPTG to the culture for 4 hours at 
37°C with shaking.  After induction, the bacteria were harvested and resuspended in binding 
buffer (1X phosphate buffer pH 7.4, 20mM Imidazole, and 8M urea) then lysed by 
sonication.  Purification of rMET-His·Tag protein and rPRO-His·Tag protein from the E. coli 
lysate was performed according to the manufacturer’s protocol for the HiTrap HP Kit (GE 
Healthcare; Piscataway, NJ).  Elution fractions were combined, dialyzed overnight against 
10mM Tris-HCl pH 7.5, and concentrated in a Centriplus centrifugal filter device (Millipore; 
Billerica, MA).   
 
Spore Adherence Assays 
 Spore adherence assays were performed as previously described (Hayman and 
others 2005).  Briefly, Vero cells were seeded onto 18-mm glass coverslips at a density of 
1×105 in 12-well plates with growth medium and allowed to grow to ~95% confluence.  
Recombinant protein was serially diluted (1μg/ml-0.001μg/ml) in growth medium.  The 12-
well plate containing the Vero monolayers was placed on ice for 30 minutes.  Following the 
30-minute incubation, old medium was removed and 2ml of new medium containing various 
dilutions of recombinant protein plus ten million (107) E. intestinalis spores were added to 
each well.  The 12-well plate was incubated on ice for 4 hours, then each coverslip was 
removed and washed thoroughly by repeatedly dunking the coverslips into phosphate 
buffered saline (PBS).  The Vero monolayers and attached spores were fixed with a 50:50 
solution of acetone:methanol for 10 minutes at room temperature.  Indirect 
immunofluorescence assays (IFA) were then performed.   
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First, the monolayers were incubated in blocking buffer (5% FBS in PBS) for 30 
minutes at room temperature.  Rabbit antiserum, which recognizes E. cuniculi and E. 
intestinalis spores, was used as primary at a concentration of 1:1,000 in blocking buffer.  
Fluorescein isothiocyanate-conjugated (FITC) anti-rabbit IgG (Rockland Immunochemicals; 
Gilbertsville, PA) was used as secondary at a concentration of 1:2,000 in blocking buffer. 
The number of attached spores was counted in at least 10 different fields at a single 
magnification.  Results are expressed as the mean +/– standard deviation or as the 
percentage of attached spores relative to the control.  Statistical significance was 
determined using the Student’s t-test.                             
  
Host Cell Infectivity Assays 
 Each spore adherence assay was set up in duplicate.  While one set of coverslips was 
processed to measure spore adherence, the other set of coverslips was processed to 
measure infectivity.  Following removal of the unbound spores, the coverslips for the 
infectivity assay were placed into a new 12-well plate with fresh medium.  These Vero 
monolayers were incubated at 37°C in 5% CO2 for ~36 hours in order to allow the attached 
spores to infect the host cells.  Following this incubation, the coverslips were washed and 
fixed as in the spore adherence assay.  The coverslips were then incubated in 0.01% Uvitex 
2B (Polysciences, Inc.; Warrington, PA) for 10 minutes at room temperature.  Uvitex 2B is a 
fluorescent dye that will bind to chitin in the microsporidia spore wall.  After washing with 
PBS, the coverslips were inverted onto a microscope slide and sealed to prevent drying of 
the monolayer.  Infected host cells were visualized at a magnification of 400X with a UV 
filter.  The total number of host cells and number of infected host cells were counted in at 
least 10 different fields at a single magnification.  Results are expressed as the percentage 
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of infected host cells per field of magnification.  Statistical significance was determined 
using the Student’s t-test.  Each spore adherence and host cell infectivity assay was 
performed in triplicate.                             
                                  
Yeast Two-Hybrid Analysis 
 The yeast two-hybrid system is an in vivo method that can be used to identify novel 
protein interactions, analyze known protein-protein interactions, or to examine the 
interactions between specific protein domains (Maple and Moller 2007).  The yeast two-
hybrid system is based on the modular nature of eukaryotic transcription factors (Causier 
and Davies 2002).  The Matchmaker™ Library Construction & Screening Kit (Clontech 
Laboratories, Inc.; Mountain View, CA) is a GAL4-based system.  GAL4 is a yeast transcription 
factor involved in galactose metabolism.  One domain known as the GAL4 DNA-binding 
domain (GAL4 DNA-BD) interacts with the appropriate DNA sequence within the promoter 
region, while the other domain is responsible for recruiting the transcriptional apparatus and 
is known as the activation domain (GAL4 AD).  Although the GAL4 DNA-BD and GAL4 AD 
domains are structurally and functionally distinct, they can not activate transcription 
independently but instead must interact non-covalently in order to initiate transcription 
(Causier and Davies 2002).   
In the Matchmaker™ yeast two-hybrid system, a plasmid encoding for a “bait” protein 
fused to the GAL4 DNA-BD is co-transformed into yeast with a plasmid that encodes for a 
“prey” protein fused to the GAL4 AD (Figure 7).  If the “bait” and “prey” proteins interact, 
then the GAL4 DNA-BD and GAL4 AD are brought together and activity of the GAL4 
transcription factor is restored.  Activation of the GAL4 transcription factor ultimately leads 
to reporter gene expression, which is measured by nutritional selection (Figure 7). 
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Construction of GAL4 DNA-BD+MADAM Fusion Vectors 
The first step in yeast two-hybrid analysis involves construction of a GAL4 DNA-BD 
plasmid that expresses the “bait” protein as a fusion with the GAL4 DNA-BD.  The pGBKT7 
vector (Figure 8) provided with the Matchmaker™ Library Construction & Screening Kit was 
used to generate a fusion protein between MADAM and the GAL4 DNA-BD.  Our initial 
construct consisted of DNA corresponding to the MADAM pro-domain through the unknown 
region with deletion of the signal sequence and transmembrane domain (Figure 9).  Deletion 
of the signal sequence and transmembrane domain ensures that neither will interfere with 
“Bait” 
GAL4 DNA-BD 
“Prey” 
GAL4 AD Reporter Gene Transcription  
(Protein Expression) 
Transform Plasmids Into Yeast 
GAL4 DNA Binding Domain 
Plasmid  
GAL4 Activation Domain 
Plasmid  
Figure 7 Diagram of yeast two-hybrid analysis. The GAL4 DNA-binding domain plasmid 
encodes for a “bait” protein fused to the GAL4 DNA-BD while the GAL4 activation domain 
plasmid encodes for a “prey” protein fused to the GAL4 AD. The “prey” can be a known 
protein or an unknown protein from a cDNA library. In either case, both plasmids are 
transformed into a suitable yeast strain. If the “bait” and “prey” proteins interact, then 
activity of the GAL4 transcription factor will be reconstituted and reporter gene expression 
will occur. Nutritional selection is often used as a measure of reporter gene expression.      
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localization of the GAL4 DNA-BD+MADAM fusion protein within the yeast.  Subsequent 
constructs were generated by deleting the unknown region, disintegrin domain, and 
metalloprotease domain of MADAM (Figure 9).  Primers were designed to introduce unique 
EcoRI and BamHI restriction sites at each end of the MADAM PCR product (Table 1).  Each 
PCR product was digested, ligated into linearized pGBKT7 vector, and transformed into 
TOP10 E. coli cells (Invitrogen; Carlsbad, CA) for plasmid propagation.    
A different cloning strategy was used to generate the pGBKT7+MADAM (∆SS/∆MET/ 
∆TM) plasmid (Figure 9).  Primers (DIS-F1-SacI: 5’-GCGAGCTCGACACATGTGGAAACGGTATC-3’ 
and DIS-R1-SacI: 5’-CGGAGCTCGACGTTTCCCTCCTCATCGTG-3’) were designed to introduce a 
SacI restriction site at the beginning and end of the metalloprotease domain sequence 
within the MADAM gene.  The pGBKT7+MADAM (∆SS/∆TM) plasmid was used as template 
to generate the PCR product lacking the region corresponding to the metalloprotease 
domain.  The PCR product was digested with SacI and ligated in order to re-circularize the 
DNA thus generating the pGBKT7+MADAM (∆SS/∆MET/∆TM) plasmid.  The plasmid was 
transformed into TOP10 E. coli cells.  The sequence for pGBKT7+MADAM (∆SS/∆MET/∆TM) 
plasmid was confirmed to ensure that the metalloprotease domain (amino acid 141-362) 
was deleted from the MADAM insert. 
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Figure 8 Diagram of the pGBKT7 vector. During our yeast two-hybrid analysis, the pGBKT7 
vector was used to express MADAM protein fused to amino acids 1-147 of the GAL4 DNA 
binding domain (GAL4 DNA-BD). Each MADAM construct was inserted into the multiple 
cloning site (MCS) of the pGBKT7 vector. In yeast, expression from the constitutive ADH1 
promoter (PADH1) results in a protein consisting of an N-terminal GAL4 DNA-BD followed by a 
c-Myc epitope tag (Δ) and the MADAM protein. The pGBKT7 vector carries an antibiotic 
resistance marker (Kanr) for selection in E. coli and a nutritional marker (TRP1) for selection 
in yeast. (adapted from Maple and Moller 2007).  
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Primer Set Sequence (5’→ 3’) Amplicon 
DIS-F1-E 
DIS-R1-BamH1 
GGAATTCTTCACTGACCCGGATGGTAAG 
GACGGATTCTGTAGCTGCTGAATTGCTGTCTCTTTGG 
MADAM 
Amino Acid 21-527 
DIS-F1-E 
DIS-R2-BamH1 
GGAATTCTTCACTGACCCGGATGGTAAG 
GACGGATCCGGCACCATCGGAGACATATC 
MADAM  
Amino Acid 21-453 
DIS-F1-E 
DIS-R3-BamH1 
GGAATTCTTCACTGACCCGGATGGTAAG 
GACGGATCCTATCTCGCCAAATTTGGATTC 
MADAM  
Amino Acid 21-362 
Figure 9 MADAM constructs used for yeast two-hybrid analysis.  The domains of full-length 
MADAM protein are shown first followed by the deletion mutants constructed for insertion 
into the pGBKT7 vector. MADAM (∆SS/∆TM) does not have the signal sequence (SS) or 
transmembrane domain (TM). MADAM (∆SS/∆UNK/∆TM) does not have the SS, unknown 
region (UNK), or the TM. In addition, the MADAM (∆SS/∆DIS/∆UNK/ ∆TM) construct does 
not possess the disintegrin domain (DIS). MADAM (∆SS/∆MET/∆TM) was generated by 
deleting the metalloprotease domain (MET) and therefore consists of only the pro-domain, 
disintegrin domain, and unknown region. Primer sets used to generate the first three 
MADAM deletion constructs are listed in Table 1. The deletion mutants were generated in 
order to better characterize which domain or domains are involved in certain protein-protein 
interactions.     
MADAM  
(∆SS/∆MET/∆TM)  
MADAM  
(∆SS/∆DIS/∆UNK/ΔTM) 
MADAM  
(∆SS/∆UNK/∆TM)  
MADAM  
(∆SS/∆TM)  
Unknown 
Disintegrin SS 
Pro-Domain 
Metalloprotease TM 
MADAM   
Table 1 Primers used to generate MADAM PCR products for insertion into the pGBKT7 
vector.  
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Transformation of Yeast with the GAL4 DNA-BD+MADAM Fusion Vectors 
Saccharomyces cerevisiae strain AH109 provided with the Matchmaker™ Library 
Construction & Screening Kit possesses 4 reporter genes (ADE2, HIS3, MEL1, and lacZ).  
The ADE2 reporter alone allows for strong selection of yeast transformants grown on 
medium lacking adenine.  A higher level of stringency is obtained when expression of the 
HIS3 reporter is screened for in addition to the ADE2 reporter by growing the yeast in 
medium lacking histidine and adenine.  The MEL1 reporter encodes for the secreted α-
galactosidase enzyme, which provides the option of performing blue-white colony screening 
of the yeast transformants in the presence of the X-α-Gal substrate.    
A small-scale yeast transformation procedure was performed to introduce each 
pGBKT7+MADAM plasmid independently into the AH109 yeast cells.  Transformations were 
performed using a lithium acetate mediated method according to the Matchmaker™Library 
Construction & Screening Kit (Clontech Laboratories, Inc.; Mountain View, CA).  Yeast 
transformants were evaluated for growth on the following synthetic dropout (SD) minimal 
medium: SD/-Trp, SD/-Trp/-His, and SD/-Trp/-Ade.   
 
Generation of the cDNA Library from E. intestinalis-Infected Vero Host Cells  
 The Matchmaker™ Library Construction & Screening Kit was used to generate a 
cDNA library from E. intestinalis-infected Vero cells.  A Vero monolayer grown in a T-75 cm2 
flask was incubated with E. intestinalis spores until numerous infected foci could be 
observed.  Total RNA was isolated from the E. intestinalis-infected Vero cells using an 
RNeasy Mini Kit (QIAGEN; Valencia, CA).  RNA quality was assessed with the Agilent 
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Bioanalyzer by the Molecular Biology Core Facility (East Tennessee State University; Johnson 
City, TN).    
The Matchmaker™ system employs the SMART (Switching Mechanism at 5’end of 
RNA Transcript) technology in order to copy mRNA transcripts into double stranded cDNA (ds 
cDNA).  First-strand cDNA synthesis was accomplished using Moloney Murine Leukemia 
Virus Reverse Transcriptase (MMLV RT) and total RNA isolated from the E. intestinalis-
infected Vero cells.  The CDS III/6 random primer (5’-ATTCTAGAGGCCGAGGCGGCCGACATG-
NNNNNN-3’ where N=A, G, C, or T) was used to prime the RNA for cDNA synthesis (Figure 
2.4).  In contrast to the oligo(dT) primer (CDS III), which only hybridizes to the poly A+ tail at 
the 3’-end of the RNA, the CDS III/6 primer will hybridize to many different sequences on the 
RNA template.  
During first-strand synthesis, MMLV RT encounters the 5’-end of the RNA template 
and with its terminal transferase activity will add a deoxycytidine (dC) stretch to the 3’-end of 
the newly synthesized single stranded cDNA (Figure 10).  An extended template is generated 
by the addition of SMART III™ Oligonucleotide (5’-AAGCAGTGGTATCAACGCAGAGT 
GGCCATTATGGCCGGG-3’), which base-pairs with the dC stretch (Figure 2.4).  MMLV RT 
switches templates and continues to replicate to the end of the SMART III™ Oligonucleotide.  
Only ss cDNA with the SMART III™ oligonucleotide sequence at the 5’-end can serve as a 
template to be exponentially amplified by long-distance PCR (LD-PCR) to produce the ds 
cDNA.  During LD-PCR of the E. intestinalis+Vero cDNA, the 5’ PCR Primer (5’-TTCCACCCAAG 
CAGTGGTATCAACGCAGAGTGG-3’) and 3’ PCR Primer (5’-GTATCGATGCCCACCCTCTAGAGGCC 
GAGGCGGCCGACA-3’) were used to amplify the cDNA and to complete the SMART III™ and 
CDS III anchors.  Following amplification, the E. intestinalis+Vero ds cDNA library was 
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purified using a CHROMA SPIN™ TE-400 Column (Clontech Laboratories, Inc.; Mountain 
View, CA).                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 Synthesis of ds cDNA using the SMART™ technology. (1) During first strand 
synthesis, reverse transcriptase (RT) is used to transcribe the mRNA into cDNA. Either a 
modified oligo(dT) (CDS III primer) or random primer (CDS III/6 primer) can be used to prime 
the RNA for cDNA synthesis. When RT encounters the 5’-end of the RNA, the terminal 
transferase activity of the enzyme will add a deoxycytidine (dC) stretch to the 3’-end of the 
single-stranded cDNA (ss cDNA). (2) The SMART III™ oligonucleotide contains an oligo(G) 
sequence at its 3’-end that will base-pair with the dC stretch on the ss cDNA. (3) RT will 
switch templates and continue replicating to the end of the SMART III™ oligonucleotide.  (4) 
Only ss cDNA with the SMART III™ oligonucleotide sequence at the 5’-end can serve as a 
template during long-distance PCR (LD-PCR). LD-PCR of the ss cDNA results in the 
generation of double-stranded cDNA (ds cDNA) with complete SMART III™ and CDS III 
anchors. (adapted from Zhu and others 2001).    
1. 
2. 
3. 
4. 
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Construction of the GAL4 AD+cDNA Library Fusion Vectors  
The pGADT7-Rec vector (Figure 11) provided with the Matchmaker™Library 
Construction & Screening Kit was used to generate fusion proteins between the E. 
intestinalis+Vero ds cDNA and the GAL4 AD.  When the SMART ds cDNA and SmaI linearized 
pGADT7-Rec vector are co-transformed into the yeast, the ds cDNA will recombine with the 
pGADT7-Rec vector to yield the complete GAL4 AD+cDNA library plasmid (Figure 12).  The 
GAL4 AD+cDNA library plasmid will express the cDNA insert as a fusion with the GAL4 AD.  
Recombination is possible because the SMART III and CDS III sequences that were 
incorporated into the cDNA are also engineered into the pGADT7-Rec vector.  Yeast repair 
enzymes will restore the SmaI linearized pGADT7-Rec vector to its circular form by 
recombining the SMART III and CDS III homologous ends present in the cDNA and vector.  
Successful constitution of the pGADT7-Rec+cDNA plasmid can be determined by growth of 
the yeast on SD/-Leu medium. 
The yeast transformation procedure was performed to introduce the SmaI linearized 
pGADT7-Rec vector and E. intestinalis+Vero ds cDNA into AH109 yeast cells that already 
contained the pGBKT7+MADAM (ΔSS/ΔTM) plasmid.  Transformations were performed 
using a lithium acetate mediated method according to the Matchmaker™Library 
Construction & Screening Kit (Clontech Laboratories, Inc.; Mountain View, CA).  Yeast 
transformants were evaluated for growth on the following synthetic dropout (SD) minimal 
medium: SD/-Leu/-Trp (double dropout or DDO) and SD/-Leu/-Trp/-His (triple dropout or 
TDO).    
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Figure 11 Diagram of the pGADT7-Rec vector (continued on page 43).  
 43 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of Positive Yeast Two-Hybrid Interactions 
Growth of the yeast transformants on TDO medium indicated a potential positive 
interaction involving the GAL4 DNA-BD+MADAM (∆SS/∆TM) protein and a GAL4 AD+cDNA 
fusion protein.  Positive yeast transformants were transferred to fresh TDO medium for 
short-term storage.  Each cDNA insert was amplified directly from the yeast colony using a 
technique known as PCR Colony Screening.  This procedure uses the Matchmaker™ GAL4 
AD LD-Insert Screening Amplimer Set (Forward PCR Primer: 5’-TTCCACCCAAGCAGTGGTATCAA 
CGCAGAGTGG-3 and Reverse PCR Primer: 5’-GTATCGATGCCCACCCTCTAGAGGCCGAGGCGGC 
Figure 11 Diagram of the pGADT7-Rec vector. During our yeast two-hybrid analysis, the 
pGADT7-Rec vector was used to express the E. intestinalis+Vero cDNA library as a fusion 
with the GAL4 activation domain (GAL4 AD). The GAL4 AD+cDNA fusions expressed from the 
pGADT7-Rec vector will possess a hemagglutinin (HA) epitope tag (■). The pGADT7-Rec 
vector carries an antibiotic resistance marker (Ampr) for selection in E. coli and a nutritional 
marker (LEU2) for selection in yeast. (adapted from Maple and Moller 2007).  
Figure 12 Homologous recombination of ds cDNA and the pGADT7-Rec vector. To introduce 
the ds cDNA into the pGADT7-Rec vector, first SMART III and CDS III sequences must be 
generated on the 5’- and 3’-terminal of the ds cDNA. When co-transformed into yeast, the ds 
cDNA will recombine with the pGADT7-Rec linearized vector thereby restoring the circular 
topology of the vector. (adapted from Clontech 2007). 
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CGAC A-3’) and Advantage® 2 PCR Polymerase Mix (Clontech Laboratories, Inc.; Mountain 
View, CA) to PCR amplify the insert from the pGADT7-Rec+cDNA vector within the yeast 
colony.  PCR amplification of the cDNA insert directly from the yeast colony provides an 
efficient preliminary screening method prior to proceeding with plasmid isolation from each 
positive yeast clone, which is costly and time consuming. 
Each PCR product was analyzed by electrophoresis on 0.7% agarose impregnated 
with ethidium bromide (0.5μg/ml).  PCR products that appeared to consist of a single DNA 
band were purified using the QIAquick PCR Purification Kit (QIAGEN; Valencia, CA) and sent 
to the Molecular Biology Core Facility (East Tennessee State University; Johnson City, TN) for 
DNA sequencing.  Each chromatogram was manually inspected for evidence of poor DNA 
sequencing results.  If the DNA sequence was usable, then the in-frame DNA sequence 
corresponding to the cDNA insert was translated to the appropriate protein sequence using 
ExPASy’s Translate Tool (Gasteiger and others 2003).  The translated protein sequence was 
analyzed using the Basic Local Alignment Tool (BLAST) to determine protein identification 
(Altschul and others 1990).       
A yeast cell can stably maintain more than one plasmid.  Therefore, yeast two-hybrid 
screening can lead to a yeast cell transformed with multiple pGADT7-Rec+cDNA plasmids.  
PCR Colony Screening revealed that 56% of the positive yeast transformants from our yeast 
two-hybrid screen actually contained multiple pGADT7-Rec+cDNA plasmids.  Often only one 
of the plasmids is responsible for the positive interaction while the others are contaminating 
plasmids (Vidalain and others 2004).  The presence of more that one pGADT7-Rec+cDNA 
vector within a single yeast colony will impair identification of the cDNA insert because 
multiple PCR bands will result in an unreadable DNA sequence.  In an attempt to select for 
the correct plasmid, all of the positive yeast transformants were grown under positive 
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selection pressure by replica plating on TDO medium every 3 days for 15 days as previously 
described (Vidalain and others 2004).  After replica plating, the yeast colonies were PCR 
screened again to determine if potential contaminating pGADT7-Rec+cDNA plasmids were 
lost.              
 pGADT7-Rec+cDNA insert and pGBKT7+MADAM (∆SS/∆TM) plasmids were isolated 
from several yeast colonies using the Yeastmaker™ Yeast Plasmid Isolation Kit (Clontech 
Laboratories, Inc.; Mountain View, CA).  pGADT7-Rec and pGBKT7 vectors contain different 
antibiotic selection markers.  pGADT7-Rec+cDNA insert and pGBKT7+MADAM (∆SS/∆TM) 
plasmids isolated from the yeast colonies were transformed and segregated in E. coli.  
Individual pGADT7-Rec+cDNA insert plasmids were isolated from the E. coli and re-
transformed into AH109 yeast.  Transformation of individual pGADT7-Rec+cDNA insert 
plasmids into the yeast allowed for the evaluation of reporter gene expression in the 
absence of the pGBKT7+MADAM (∆SS/∆TM) plasmid.  In addition, positive interactions were 
confirmed by co-transformation of yeast with certain pGADT7-Rec+cDNA insert plasmids and 
various pGBKT7+MADAM plasmids.   
 
Construction of the GAL4 AD+Polar Tube Protein 1, 2, and 3 Fusion Vectors 
 The Matchmaker™Library Construction & Screening Kit provides the components 
necessary to introduce ds cDNA into the SmaI linearized pGADT7-Rec vector.  However, we 
were interested in introducing genes specific for the polar tube proteins into the pGADT7-
Rec vector for yeast two-hybrid analysis.  To accomplish this, we used primers to introduce 
the SMART III sequence to the 5’-terminal and the CDS III sequence to the 3’-terminal of 
each PCR product.  By introducing these sequences, the genes could be directly inserted 
into the pGADT7-Rec vector by recombination-mediated cloning in the yeast cells.  The first 
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round of PCR used primers that were primarily specific for the gene of interest but also 
contained 25 bases corresponding to the SMART III sequence for the forward primer and 21 
bases corresponding to the CDS III sequence for the reverse primer (Table 2).  A second 
round of PCR was used to finish the SMART III and CDS III anchor sequences using the 
Forward PCR Primer: 5’-TTCCACCCAAGCAGTGGTATCAACGCAGAGTGG-3’ and Reverse PCR 
Primer: 5’-GTATCGATGCCCACCCTCTAGAGGCCGAGGCGGCCGACA-3’.  A small-scale yeast 
transformation procedure was performed to introduce the SmaI linearized pGADT7-Rec 
vector and each individual E. cuniculi or E. intestinalis polar tube protein PCR product into 
AH109 yeast cells that already contained the pGBKT7+MADAM (ΔSS/ΔTM) vector. Yeast 
transformations were performed using the lithium acetate mediated method according to 
the Matchmaker™Library Construction & Screening Kit (Clontech Laboratories, Inc.; 
Mountain View, CA).  Yeast transformants were evaluated for growth on DDO, TDO, and QDO 
medium.    
  
 
Primer Set Sequence (5’→ 3’) Amplicon 
EcPTP1-F1 
EcPTP1-R1 
CAAGCGAGAGTGGCCATTATGGCCCATGAAAGGTATTTCTAAG 
GAGGCCGAGGCGGCCGACATGGCAGCATTGGACAGCAGTG 
E. cuniculi PTP1 (ECU06_0250) 
Amino Acid 1-395 
EcPTP2-F1 
EcPTP2-R1 
CAAGCGAGAGTGGCCATTATGGCCCATGTTGTTACTTCTCGCC 
GAGGCCGAGGCGGCCGACATGCTCTAGACCCTCGCCGTC 
E. cuniculi PTP2 (ECU06_0240) 
Amino Acid 1-277 
EcPTP3-F2 
EcPTP3-R2 
CAAGCGAGAGTGGCCATTATGGCCCGTGGGGGGATCCATTCCC 
GAGGCCGAGGCGGCCGACATGCCGGGCCTTTGCCGCCTC 
E. cuniculi PTP3 (ECU11_1440) 
Amino Acid 141-574 
EiPTP1-F1 
EiPTP1-R1 
CAAGCGAGAGTGGCCATTATGGCCCATGAAAGGTATTTCTAAGG 
GAGGCCGAGGCGGCCGACATGGCATGGTGGTGGGCAGCAAGC 
E. intestinalis PTP1 (AJ880382) 
Amino Acid 1-371 
EiPTP2-F1 
EiPTP2-R1 
CAAGCGAGAGTGGCCATTATGGCCCATGTTGTTACTTCTCAAGC 
GAGGCCGAGGCGGCCGACATGCTCTAGACCTTCGCCGTC 
E. intestinalis PTP2 (AX007052) 
Amino Acid 1-275 
Table 2 Primer used to generate E. cuniculi and E. intestinalis polar tube protein PCR products for insertion into the 
pGADT7-Rec vector.   
∗ Underlined bases represent either the SMART III™ terminal sequence (forward primer) or the CDS III terminal sequence 
(reverse primer). Introducing the SMART III™ and CDS III anchors allows for recombination of the PCR product with the 
pGADT7-Rec vector in vivo.  
In vitro Transcription, Translation, and Co-Immunoprecipitation 
 Protein-protein interactions identified during our yeast two-hybrid screening were 
confirmed using in vitro transcription/translation and co-immunoprecipitation (Figure 13).  
The pGBKT7 and pGADT7-Rec vectors can be used directly for in vitro transcription, 
translation, and co-immunoprecipitation procedures because they possess a T7 RNA 
polymerase promoter and either a c-Myc (pGBKT7) or HA (pGADT7-Rec) epitope tag.  
Because the T7 promoter is located downstream of the GAL4 coding sequence, the proteins 
expressed during the in vitro procedures will not contain the GAL4 DNA-BD or GAL4 AD.  In 
vitro transcription and translation were accomplished using the PROTEINSCRIPT® II Kit 
(Ambion, Inc.; Austin, TX).  Briefly, transcription with the T7 bacteriophage RNA polymerase 
was followed by translation in an optimized rabbit reticulocyte lysate.  In vitro translated 
proteins were labeled with L-[35S]-methionine (GE Healthcare; Piscataway, NJ).   
In vitro co-immunoprecipitation was performed using the Matchmaker™ Co-IP Kit 
(Clontech Laboratories, Inc.; Mountain View, CA).  Briefly, the in vitro translated 35S-
methionine labeled “bait” and “prey” proteins were combined and incubated at room 
temperature for 1 hour.  Depending on the experiment, either the c-Myc Monoclonal 
Antibody or HA-Tag Polyclonal Antibody was added and incubated with the reaction for 1 
hour.  Immunoprecipitation was accomplished by the addition of Protein A Beads followed by 
a 1 hour incubation at room temperature.  Unbound proteins were removed by extensive 
washing of the Protein A Beads.  Any remaining protein-protein-antibody complexes were 
removed from the Protein A Beads by heating in the presence of SDS-PAGE Loading Buffer.  
The proteins were analyzed by SDS-PAGE followed by autoradiography. 
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Figure 13 Overview of in vitro transcription, translation, and co-immunoprecipitation. Protein 
interactions identified during our yeast two-hybrid screen were confirmed using in vitro 
methods. 35S-labeled proteins were generated from the pGBKT7+MADAM and pGADT7-
Rec+cDNA plasmids using in vitro transcription and translation procedures. Protein 
interactions were confirmed using co-immunoprecipitation procedures according to the 
Matchmaker™ Co-IP Kit. (adapted from Clontech 2006). 
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CHAPTER 3 
RESULTS 
 
Recombinant Expression of MADAM Protein for Polyclonal Antibody Production 
To begin characterization of the MADAM protein, a histidine-tagged recombinant 
MADAM (rMADAM-His·Tag) protein was expressed in E. coli.  Protein lysate collected from 
non-induced and induced E. coli cultures that contain the pET-21a+MADAM (∆SS/∆TM) 
plasmid were analyzed by SDS-PAGE and Western blot (Figure 14).  Upon induction with 
IPTG, the E. coli produced a protein with an apparent molecular weight of ~61kDa which is 
comparable to the predicted size of ~59kDa for the rMADAM-His·Tag protein and was 
specifically recognized by the anti-His·Tag antibody.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 2 3 
~61kDa 
4 5 6 
~61kDa 
Figure 14 Expression of rMADAM-His·Tag protein. Protein lysate from the E. coli cultures 
were separated by SDS-PAGE and either stained with Coomassie Brilliant Blue R (Lane 1-3) 
or processed for Western analysis (Lane 4-6) using an anti-His·Tag antibody. Upon induction 
with IPTG, a protein of ~61kDa was observed (Lane 3) and this protein was specifically 
recognized by the anti-His·Tag antibody (Lane 6). The rMADAM-His·Tag protein was not 
observed in the non-induced E. coli protein lysate (Lane 2 and Lane 5). The molecular 
weight markers are in Lane 1 and Lane 4. 
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Western Analysis of MADAM Protein from E. cuniculi and E. intestinalis 
Following confirmation of rMADAM-His·Tag protein expression, several milligrams of 
the rMADAM-His·Tag protein was purified by nickel affinity chromatography and used as 
antigen for polyclonal antibody production in rabbits.  Total IgG antibodies were purified from 
the rabbit serum and used for Western analysis of E. cuniculi and E. intestinalis spore 
protein in order to determine specificity.  Full-length MADAM protein from E. cuniculi is 
predicted to be ~61kDa.  After removal of the signal sequence, the MADAM protein should 
be ~59kDa.  Antibodies generated against the rMADAM-His·Tag protein did recognize a 
protein of ~60kDa from both E. cuniculi and E. intestinalis (Figure 15).  However, these 
antibodies also recognized a protein of ~143kDa from E. cuniculi and E. intestinalis spores 
(Figure 15).   
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
1 2 3 
~143kDa 
~60kDa 
Figure 15 Western analysis of MADAM protein. Protein lysates from E. cuniculi (Lane 2) and 
E. intestinalis (Lane 3) spores were separated by SDS-PAGE then processed for Western 
analysis. Antibodies generated against the rMADAM-His·Tag protein recognized proteins of 
~61kDa and ~143kDa from both E. cuniculi and E. intestinalis. MADAM protein from E. 
cuniculi is predicted to be ~61kDa or ~59kDa after removal of the signal sequence. The 
molecular weight markers are in Lane 1. 
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Identification of the ~143kDa Protein Recognized by the Anti-rMADAM-His·Tag Antibodies 
Mass-spectrometry based proteomics is one of the more common experimental 
approaches used to identify individual proteins within a complex protein mixture (Aebersold 
and Mann 2003).  Purification of individual proteins within a sample is accomplished by 
techniques such as two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) or 
immunoprecipitation if a specific antibody is available.  Following the purification step, 
individual proteins are separated by SDS-PAGE and proteins spots or bands are excised from 
the gel.  Digestion of the protein into peptides is followed by mass-spectrometry analysis.  
The protein is identified by matching the peptide sequences against a protein sequence 
database. 
Unfortunately, attempts to separate the E. cuniculi spore proteins by 2D-PAGE in 
order to identify the ~143kDa E. cuniculi protein recognized by the anti-rMADAM-His·Tag 
antibody were unsuccessful (data not shown).  Also, we were unable to purify the ~143kDa 
E. cuniculi protein using a classical immunoprecipitation approach (data not shown). 
However, we were able to purify the ~143kDa E. cuniculi protein by incubating total protein 
lysate from E. cuniculi spores with a piece of nitrocellulose membrane that was pre-
incubated with the anti-rMADAM-His·Tag antibody.  E. cuniculi proteins that bound to the 
antibody on the membrane were separated by SDS-PAGE and either stained with Coomassie 
Brilliant Blue R or processed for Western analysis.  The E. cuniculi protein at ~143kDa was 
excised from the Coomassie stained gel and was sent for mass-spectrometry and protein 
sequence database analysis (Figure 16).  The protein was identified as E. cuniculi polar tube 
protein 3 (PTP3).  PTP3 has a predicted molecular weight of ~136kDa and has been shown 
to run at ~150kDa by SDS-PAGE (Peuvel and others 2002). 
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Further examination of the pre-screened rabbit serum demonstrated that the rabbit 
already had antibodies against a protein of the same molecular weight as the ~143kDa 
protein or presumably PTP3 (Figure 17).  Antibodies from the rabbit pre-immune serum did 
not react with the rMADAM-His·Tag protein, which indicates that this rabbit did not have 
antibodies against MADAM prior to immunization (Figure 17).  The initial Western analysis of 
the rabbit pre-immune serum did not uncover this high molecular weight protein.  Isolation 
of protein from microsporidia spores is not trivial and results can vary depending on factors 
such as spore stock, composition of the lysis buffer, and boiling conditions.   
Figure 16 Purification and Identification of the ~143kDa E. cuniculi protein.  A piece of 
nitrocellulose membrane pre-incubated with anti-rMADAM-His·Tag antibody was incubated 
with protein lysate from E. cuniculi. Proteins that did not interact with the antibody were 
washed away while the bound E. cuniculi proteins were eluted. The proteins were then 
separated by SDS-PAGE and either stained with Coomassie Brilliant Blue R (Lane 2) or 
processed for Western analysis (Lane 4) using the anti-rMADAM-His·Tag antibody. As 
observed in Lane 2 and 4, the ~143kDa protein was isolated. The protein band at ~143kDa 
in Lane 2 was excised and sent to Midwest Bio Services, LLC (Overland Park, KS) for mass 
spectrometry analysis. The protein was identified as E. cuniculi polar tube protein 3 (PTP3). 
The molecular weight markers are in Lane 1 and Lane 3.  
 
3 4 
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~143kDa 
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Microsporidia, particularly E. cuniculi, naturally infect rabbits and finding a naïve 
rabbit for antibody production will continue to be a challenge.  In fact, western analysis of 
several other pre-immune sera from the same company and another company 
demonstrated that the rabbits already possess antibodies to various proteins from both E. 
cuniculi and E. intestinalis (data not shown).  Future attempts to generate anti-rMADAM-
His·Tag antibody will be accomplished in rodents. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 Western analysis of E. cuniculi and E. intestinalis protein using the rabbit pre-
immune serum. Protein lysates from E. cuniculi (Lane 2) and E. intestinalis (Lane 3) spores 
were separated by SDS-PAGE then processed for Western analysis. Antibodies from the 
rabbit pre-immune serum recognize protein at ~143kDa from E. cuniculi and E. intestinalis. 
However, these antibodies do not recognize the rMADAM-His·Tag protein (Lane 4). The 
molecular weight markers are in Lane 1. 
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Localization of the MADAM Protein within E. cuniculi and E. intestinalis 
Immunoelectron microscopy was performed on E. cuniculi and E. intestinalis infected 
RK-13 cells using the anti-rMADAM-His·Tag antibodies to determine the location of the 
MADAM protein within the spore.  As a control, immunolabeling was first performed using 
antibodies purified from the pre-immune serum.  Although antibodies from the pre-immune 
serum reacted with E. cuniculi and E. intestinalis proteins by Western analysis, no specific 
labeling of the microsporidia was observed by TEM (Figure 18).   
 
     
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 Immunolabeling of E. intestinalis infected RK-13 cells using antibodies from the 
pre-immune serum. Sections of E. intestinalis infected RK-13 cells were immunolabeled 
with antibodies from the rabbit pre-immune serum followed by a 15nm gold-labeled goat 
anti-rabbit antibody. As observed in this image, no specific labeling can be observed within 
some of the major spore structures including the polar sac (PS), anchoring disk (AD), polar 
tube (PT), plasma membrane (PM), endospore (EN), and exospore (EX). Also, no specific 
labeling was observed within the host cell or within other stages of spore development (data 
not shown).      
500 nm 
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Immunolabeling with anti-rMADAM-His·Tag antibodies demonstrates that MADAM is 
localized to the polar sac-anchoring disk complex of mature E. cuniculi and E. intestinalis 
spores (Figures 19 and 20).  The polar sac-anchoring disc complex is a bell-shaped structure 
located at the spore apex where the spore wall is thin (Wittner 1999).  The polar sac is a 
vesicular structure composed of an electron-dense substance surrounded by a unit 
membrane (Wittner 1999).  The polar sac encircles the proximal portion of the polaroplast.  
The polar tube enters the polar sac and terminates at a biconvex, layered structure known 
as the anchoring disk (Wittner 1999).  The polar sac-anchoring disk complex serves as an 
anchor between the polar tube and spore wall during polar tube extrusion.  By immuno-
electron microscopy, MADAM appears to localize to the anchoring disk more often than the 
polar sac.  
 In addition to being localized to the polar sac-anchoring disk complex, MADAM can 
be found in the exospore and plasma membrane of E. intestinalis spores (Figure 20).  In E. 
cuniculi, MADAM is only localized to the polar sac-anchoring disk complex (Figure 19).  The 
exospore is the electron-dense, surface exposed layer of the microsporidia spore wall 
(Wittner 1999).  In the spore wall, the plasma membrane lines the internal surface of the 
endospore (Wittner 1999).  A difference in MADAM localization between E. cuniculi and E. 
intestinalis was unexpected and the relevance of this variation should be examined further.    
Expression of MADAM appears to be developmentally or differentially regulated in E. 
intestinalis (Figure 20 and 21).  During the meront to sporont transition, MADAM expression 
occurs internally and on the periphery (Figure 21).  During sporoblast development, MADAM 
expression becomes more intense and delineated (Figure 21).  In some spores, MADAM 
expression occurs on the plasma membrane while in other spores expression occurs on the 
exospore (Figure 20).  Expression appears to be limited to one or the other location and 
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rarely does MADAM localize to both the exospore and plasma membrane within the same 
spore.  Localization of MADAM to different structures within E. intestinalis spores may be an 
indication of spore maturity.  Exospore localization occurs on spores that are forming an 
electron dense outer exospore layer (Figure 20).  Localization of MADAM to the plasma 
membrane appears to occur in spores without this electron dense exospore layer (Figure 
20).   
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Figure 19 Localization of MADAM within E. cuniculi. Sections of E. cuniculi infected RK-13 
cells were immunolabeled with antibodies against the rMADAM-His·Tag protein followed by 
a 15nm gold-labeled goat anti-rabbit antibody. (A-D) Immunolabeling is observed within the 
polar sac (PS) and anchoring disk (AD) of mature E. cuniculi spores. (B-C) The polar tube 
(PT) emerges from the polar sac-anchoring disk complex. (C) No significant 
immunolabeling is observed in the exospore (EX) endospore (EN), or plasma membrane 
(PM) of the E. cuniculi spores. (D) Immunolabeling is observed within the anchoring disk 
(AD) following polar tube extrusion.   
AD 
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Figure 20 Localization of MADAM within E. intestinalis. Sections of E. intestinalis infected 
RK-13 cells were immunolabeled with antibodies against the rMADAM-His·Tag protein 
followed by a 15nm gold-labeled goat anti-rabbit antibody. (A-E) Immunolabeling is 
observed within the polar sac (PS) and anchoring disk (AD) of mature E. intestinalis spores. 
In contrast to E. cuniculi, localization of MADAM is also observed within the plasma 
membrane (PM) and exospore (EX) of E. intestinalis. MADAM does not appear within the 
endospore (EN). (A-B) The polar tube (PT) emerges from the polar sac-anchoring disk 
complex. (D) Immunolabeling of an E. intestinalis spore that has extruded its polar tube. 
(E) In the upper spore, MADAM is primarily located on the exospore (EX). In the lower 
spore, MADAM is primarily located on the plasma membrane (PM). Typically, MADAM does 
not localize to both the exospore and plasma membrane within the same spore.  
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Figure 21 Localization of MADAM within various stages of E. intestinalis development. 
Sections of E. intestinalis infected RK-13 cells were immunolabeled with antibodies against 
the rMADAM-His·Tag protein followed by a 15nm gold-labeled goat anti-rabbit antibody. (A) 
Various developmental stages including the meront to sporont transition (M-ST), 
sporoblasts (SB), and spores (S) are observed within the parasitophorous vacuole (arrow-
heads). In this image, host cell mitochondria (∗) can be observed lining the outside of the 
parasitophorous vacuole. (B) During the transition between the meront and sporont, 
immunolabeling is observed internally (I) and along the periphery (P). (C) As development 
progresses from sporonts to sporoblasts (SB), immunolabeling is more concentrated along 
what will become the spore wall (SW).  
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Spore Adherence and Host Cell Infectivity Assays 
A series of in vitro assays were performed to determine if rMADAM-His·Tag protein 
can be used to manipulate microsporidia spore adherence and/or host cell infection.  In 
addition to the original rMADAM-His·Tag protein, other recombinant MADAM deletion 
mutants were also evaluated (Figure 22).  rMET-His·Tag protein consists of the MADAM 
metalloprotease domain while the rPRO-His·Tag protein consists of the MADAM pro-domain.  
Although the disintegrin domain would be the most likely MADAM domain involved in 
adherence, our attempts to express the disintegrin domain alone were unsuccessful.   
 
 
 
 
 
 
 
 
 
 
 
 
 
rMADAM-His·Tag protein was unable to significantly inhibit E. cuniculi spore 
adherence to the host cell monolayer (Figure 23).  However, rMADAM-His·Tag protein 
inhibited E. intestinalis spore adherence to the host cell monolayer by 50-80% (Figure 23).  
Figure 22 MADAM constructs introduced into the pET-21a vector.  The domains of full-length 
MADAM protein are shown first followed by the deletion mutants constructed for insertion 
into the pET-21a vector. rMADAM-His·Tag does not have the signal sequence (SS) or 
transmembrane domain (TM). rMET-His·Tag consists of only the MADAM metalloprotease 
domain. rPRO-His·Tag consists of only the MADAM pro-domain. Attempts to express only the 
MADAM disintegrin domain were unsuccessful. The deletion mutants were generated in 
order to better characterize which domain or domains may be involved in spore adherence 
or host cell infection.     
Unknown 
Disintegrin SS 
Pro-Domain 
Metalloprotease TM 
MADAM   
rMADAM-His·Tag  6XHis·Tag  
rMET-His·Tag  6XHis·Tag  
rPRO-His·Tag 6XHis·Tag  
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Addition of rMET-His·Tag or rPRO-His·Tag protein did not result in significant inhibition of E. 
intestinalis spore adherence to the host cell monolayer (Figure 23). The ability of rMADAM-
His·Tag protein to inhibit E. intestinalis spore adherence but not E. cuniculi spore adherence 
could be related to the differences in MADAM localization between the two species.  As 
stated previously, MADAM is localized on the surface exposed exospore of E. intestinalis but 
not E. cuniculi.   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23 Analysis of spore adherence in the presence of recombinant MADAM proteins. 
Various dilutions of each recombinant protein were incubated on the host cell monolayers in 
the presence of E. cuniculi (Ec) or E. intestinalis (Ei) spores. Following an incubation period, 
the monolayers were washed to remove unbound spores. The host cell monolayers and 
bound spores were processed by indirect immunofluorescence methods. The number of 
adherent spores was determined and the data from three independent experiments are 
represented. Significance was determined using the Student’s t-test and p-values less than 
0.0001 are shown (*). rMADAM-His·Tag protein does not significantly inhibit E. cuniculi 
spore adherence (--■--) but does decrease E. intestinalis spore adherence (—●—) by as much 
as 80%. E. intestinalis spore adherence is not significantly decreased in the presence of 
recombinant protein consisting of the MADAM pro-domain (–□–) or MADAM metalloprotease 
domain (–○–).       
Protein Concentration (µg/ml) 
*
* *
*
Pro-Domain - Ei Spores 
Met-Domain - Ei Spores 
Full Length - Ei Spores 
Full Length - Ec Spores 
Sp
or
e 
Ad
he
re
nc
e 
- P
er
ce
nt
ag
e 
of
 C
on
tr
ol
 
0 0.001 0.01 0.1 1.0
0
20
40
60
80
100
120
140
 62 
Host cell infectivity assays revealed that rMADAM-His·Tag protein only decreased the 
occurrence of host cell infection by less than 20% (Figure 24).  This result is unexpected 
given that the rMADAM-His·Tag protein decreases E. intestinalis spore adherence by 50%-
80%.  As a control, spore adherence and host cell infectivity assays using chondroitin sulfate 
A (CSA) were included.  CSA decreased E. intestinalis spore adherence and host cell 
infection by at least 40%.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24 Analysis of host cell infection in the presence of recombinant MADAM proteins. 
Various dilutions of each recombinant protein were incubated on the host cell monolayers in 
the presence of E. intestinalis spores. Following an incubation period, the monolayers were 
washed to remove unbound spores and returned to tissue culture for several days. The host 
cell monolayers were washed, fixed, and stained with Uvitex 2B. The number of infected and 
non-infected host cells per field was determined. Duplicate monolayers were processed for 
spore adherence assays. Significance was determined using the Student’s t-test and p-
values less than 0.0001 (*) and equal to 0.0039 (**) are shown. rMADAM-His·Tag protein  
(    ) inhibited E. intestinalis spore adherence by ~50% but only decreased the percentage of 
infected host cells by ~20%. Chondroitin sulfate A or CSA (    ) was used as a positive control 
and was able to decrease E. intestinalis spore adherence and host cell infection by at least 
40%.    
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Identification of Potential Protein-Protein Interactions Involving MADAM 
As a protein sharing sequence homology with members of the ADAM family, it is 
possible that the MADAM protein serves several functions.  To better understand what role 
MADAM serves, it is necessary to identify potential substrates or binding partners.  MADAM 
has the potential to interact with numerous host cell and/or microsporidia proteins.  A yeast 
two-hybrid approach was used to identify such protein-protein interactions involving MADAM.   
A pGBKT7+MADAM (∆SS/∆TM) plasmid encoding for a GAL4 DNA-BD+MADAM 
(∆SS/∆TM) fusion protein was generated and transformed into AH109 yeast.  Several yeast 
colonies (>100) grew on medium lacking tryptophan (SD/-Trp), which indicates that the 
transformants contain the pGBKT7+MADAM (∆SS/∆TM) plasmid.  The GAL4 DNA-BD+ 
MADAM (∆SS/∆TM) fusion protein was evaluated for transcriptional auto-activation and 
toxicity to the yeast cells.  First, SD/-Trp/-His and SD/-Trp/-Ade medium were used to 
determine if the yeast transformants were capable of activating the HIS3 and ADE2 reporter 
genes.  Yeast containing the pGBKT7+MADAM (∆SS/∆TM) plasmid did not grow in the 
absence of adenine or histidine, indicating that the GAL4 DNA-BD+ MADAM (∆SS/∆TM) 
fusion protein could not activate transcription of the reporter genes.  In addition, toxicity of 
the GAL4 DNA-BD+MADAM (∆SS/∆TM) fusion protein was evaluated by comparing the 
growth rate of yeast containing the pGBKT7-MADAM (∆SS/∆TM) plasmid and yeast 
containing the “empty” pGBKT7 vector.  Yeast containing the pGBKT7+MADAM (∆SS/∆TM) 
plasmid grew just as well as yeast containing the “empty” pGBKT7 vector. These data 
indicate that the pGBKT7+MADAM (∆SS/∆TM) plasmid is suitable for yeast two-hybrid 
analysis. 
A cDNA library was generated using the Matchmaker™ Library Construction and 
Screening Kit and RNA isolated from E. intestinalis-infected Vero cells.  The GAL4 AD+cDNA 
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insert plasmids were generated by transforming the pGADT7-Rec vector and cDNA into the 
yeast simultaneously.  In addition, these yeast were already contained the pGBKT7+MADAM 
(∆SS/∆TM) plasmid.  The yeast transformants were evaluated for growth on SD/-Leu/-Trp 
and SD/-Leu/-Trp/-His or TDO medium.  Growth of the AH109 yeast on medium lacking 
tryptophan and leucine would indicate that the transformants contain the pGBKT7+MADAM 
(ΔSS/ΔTM) plasmid and at least one pGADT7-Rec+cDNA insert plasmid.  Yeast 
transformants growing on TDO medium would indicate a positive interaction between the 
GAL4 DNA-BD+MADAM (ΔSS/ΔTM) fusion protein and a GAL4 AD+cDNA fusion protein.  
Over 1,000 colonies grew on the SD/-Leu/-Trp medium.  Over a period of several days, 89 
yeast colonies grew on the TDO medium.  All of the 89 yeast colonies were transferred to 
fresh TDO medium and QDO (SD/-Leu/-Trp/-His/-Ade) medium to screen for stringency of 
the interactions. 
To identify the cDNA from the positive yeast colony the cDNA insert must first be 
“rescued” by Plasmid Isolation or PCR Colony Screening.  PCR Colony Screening was 
selected because it offers an efficient initial screening method.  Isolating the plasmid from 
each positive yeast clone would have been more costly and time consuming.  PCR 
amplifications of the cDNA insert from each yeast colony were separated by agarose gel 
electrophoresis (Figure 25).  Fifty-six percent of the yeast colonies resulted in PCR products 
with multiple DNA bands.   
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 PCR products that appeared to be a single PCR band were purified and sent to the 
Molecular Biology Core Facility (East Tennessee State University; Johnson City, TN) for DNA 
sequencing.  If the DNA sequence was usable, then the in-frame DNA sequence 
corresponding to the cDNA insert was translated to the appropriate protein sequence using 
ExPASy’s Translate Tool (Gasteiger and others 2003).  The translated protein sequence was 
analyzed using the Basic Local Alignment Tool (BLAST) to determine the protein 
identification (Altschul and others 1990).  Protein identifications from sequenced cDNA 
inserts were compiled and examined for evidence of potential false-positive interactions 
(Table 3).   
 
 
 
Figure 25 Amplification of cDNA inserts from potential positive yeast clones. cDNA inserts 
were amplified from a scraping of each yeast colony using primers specific for the pGADT7-
Rec vector. PCR products were then separated by agarose gel electrophoresis. The DNA 
ladder can be observed in the far left lane followed by PCR bands representative of cDNA 
inserts. Some colonies possess more than one pGADT7-Rec vector as evident by the 
appearance of several PCR bands within a single sample. Although all 89 colonies were 
screened by PCR, this gel is only representative of eighteen of those colonies.   
 Colony # Protein Organism NCBI Identification E-Value Growth on QDO 
2 serine/threonine protein kinase Rattus norvegicus NP_775449.1 8×10-4 3 
3 leucine rich repeat containing 22  Homo sapiens NP_001017924 5×10-7 3 
4 No similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
7 similar to hornerin Homo sapiens XP_001127437 0.11 3 
8 No similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 2 
10 unnamed protein product Homo sapiens BAC87430 0.7 3 
11 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
12 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
13 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
14 No similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 2 
16 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
19 No similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 2 
22 methionine aminopeptidase 2 E. intestinalis AAR04555 2×10-69 3 
23 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
25 No similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
29 NAD-dependent epimerase Roseiflexus sp. ZP_01355602 1.7 3 
30 No similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
31 No similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
32 No similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
Table 3 Basic Local Alignment Tool (BLAST) identification of PCR amplified cDNA inserts from yeast colonies 
demonstrating potential interactions involving the MADAM (∆SS/∆TM) protein. *  
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Colony # Protein Organism NCBI Identification E-Value Growth on QDO 
33 histone H3 E. cuniculi NP_597654 6×10-55 2 
34 histone H3 E. cuniculi NP_597654 6×10-57 2 
35 no similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 2 
37 no similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 2 
40 polar tube protein 3 precursor E. cuniculi Q8MTP3 4×10-104 3 
42 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
46 GATA zinc finger transcription factor E. cuniculi NP_584553  2 
50 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
56 polar tube protein 3 precursor E. cuniculi Q8MTP3 2×10-9 3 
61 polar tube protein 3 precursor E. cuniculi Q8MTP3 7×10-69 3 
62 no similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
64 unnamed protein product Homo sapiens BAC85628 2×10-23 3 
67 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
68 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
69 no similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
70 hypothetical protein ORF501 Costesia plutellae AAZ04273 0.19 3 
71 hypothetical protein ECU07_1800 E. cuniculi NP_586107 0.059 3 
76 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
77 no similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
Colony # Protein Organism NCBI Identification E-Value Growth on QDO 
79 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 2 
81 no similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
82 no similarity found ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
84 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
86 Macrophage migration inhibitory factor Homo sapiens CAG46452 1×10-28 3 
88 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
89 unreadable sequence data ⎯⎯⎯⎯⎯ ⎯⎯⎯⎯⎯ ⎯⎯⎯ 3 
* PCR products from 45 of the original 89 positive yeast transformants were sent for sequencing analysis. 31% of the 
DNA sequences were unusable and another 33% of them resulted in no protein identification. We were able to obtain 
protein identifications from the remaining DNA sequences. BLAST results with E-values approaching 1.0 are not 
considered to be reliable. Yeast colonies that do not grow on QDO medium (8) represent either false-positives or true 
protein-protein interactions that are weak. Yeast colonies that do grow on QDO medium (9) are considered to be strong 
protein-protein interactions.     
Fifteen of the 45 PCR products resulted in a sequence without homology to any 
protein in the NCBI database and are listed as “no similarity found” (Table 3).  These PCR 
products are a consequence of pGBKT7-Rec+cDNA plasmids with cDNA inserts that are 
apparently out-of-frame.  Yeast transformed with out-of-frame pGBKT7-Rec+cDNA plasmids 
can yield a positive interaction by producing short peptides that interact with the GAL4 DNA-
BD fusion protein but do not represent a biologically relevant interaction.  These yeast two-
hybrid interactions are considered to be false-positives (Vidalain and others 2004). 
Fourteen of the 45 PCR products resulted in an unreadable DNA sequence.  A 
chromatogram was classified as unreadable or unusable in cases where the sequence 
corresponding to the cDNA insert consisted of single nucleotide tracts (Figure 26), “mixed 
peaks”, or areas of poor resolution.  PCR products that appear as a single DNA band may 
consist of additional DNA bands that do not appear on the agarose gel because they are too 
small or are superimposed products.  
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There are at least two categories of false-positives: “biological” false-positives are 
defined as protein-protein interactions that occur in the yeast cell but do not occur in the 
organism under study and “technical” false-positives are protein-protein interactions that 
occur during a yeast-two hybrid screen due to the limitations of the system (Vidalain and 
others 2004).  Although “biological” false-positives are difficult to eliminate, several of the 
“technical” false-positives can be avoided.  One type of false-positive can arise due to the 
ability of a yeast cell to stably maintain more than one plasmid.  Yeast two-hybrid screening 
can lead to a yeast cell transformed with multiple pGADT7-Rec+cDNA plasmids.  Screening 
of our positive yeast colonies revealed that 56% of the transformants actually contained 
Figure 26 Chromatogram demonstrating an unreadable DNA sequence. Some PCR products 
that appeared to consist of a single band were shown to possess other contaminating DNA 
products most likely from other cDNA inserts. All of the unreadable DNA sequences were not 
usable from the point at which the cDNA insert sequence should start. For this 
chromatogram it would have been around base 180.      
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multiple pGADT7-Rec+cDNA plasmids as evident by the appearance of multiple PCR 
products from a single colony.   
In an attempt to select for the correct plasmid, all of the yeast transformants were 
grown under positive selection pressure by replica plating on TDO medium every 3 days for 
15 days as previously described (Vidalain and others 2004).  After replica plating the yeast 
were PCR screened again to determine if any had lost potential contaminating pGADT7-
Rec+cDNA plasmids.  First, colonies #1-38 were PCR screened and 18 of the colonies 
appeared to lose their contaminating plasmids.  However, several of these PCR products 
were again sent for sequencing and several still did not result in a usable DNA sequence.  
Attempts to purify individual PCR bands from the agarose gel for sequencing also did not 
increase the quality of the DNA sequence.  Future attempts to identify the cDNA inserts will 
be done by isolating individual plasmids from the yeast colonies for sequence analysis. 
Examination of the usable sequence data, revealed 16 potential protein 
identifications.  At least 6 of these sequences (colony #2, 7, 10, 29, 70, and 71) led to 
BLAST results with e-values approaching 1.0, which indicates that the quality of the DNA 
sequence may not be high enough to reliably identify the cDNA insert (Vidalain and others 
2004).  In addition, at least 3 sequences (colony #33, 34, and 46) led to the identification of 
proteins that may result in false-positive interactions because they are inherently “sticky” 
and are commonly classified as generating false-positive interactions during yeast two-
hybrid analysis (Table 4).      
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 After evaluating the cDNA insert data, we found methionine aminopeptidase 2 
(MetAP2) and polar tube protein 3 (PTP3) to be the most interesting potential partners for 
the MADAM protein.  MetAP2 is an essential participant in the N-terminal methionine 
excision pathway and is responsible for post-translational modification of nascent proteins 
by removing the N-terminal methionine (Upadhya and others 2006).  Fumagillin, one of the 
therapies used for the treatment of human microsporidiosis, covalently binds to MetAP2 and 
specifically inhibits the peptidase activity.  Although the potential interaction between 
MetAP2 and MADAM is worth characterizing further, we were more interested in 
investigating PTP3 protein.  First, this cDNA insert was positively identified from sequencing 
data from 3 separate colonies #40, 56, and 61 (Table 3).  PCR screening of colony #10, 31, 
57, and 59 resulted in DNA bands the same size as the 3 other cDNA inserts that were 
identified as PTP3.  These colonies were assumed to contain the PTP3 cDNA insert.  In 
addition, a potential interaction between MADAM and PTP3 seems likely because MADAM is 
located in the polar sac-anchoring disk complex.   
Protein Number of Times Found as False-Positive 
heat shock proteins 16 
ribosomal proteins 14 
cytochrome oxidase 5 
proteasome subunits 4 
Ferritin 4 
other mitochondrial proteins 3 
transfer-RNA synthase 3 
collagen-related proteins 3 
zinc-finger containing proteins 3 
Table 4 Proteins commonly identified as false-positives during yeast two-hybrid analysis.  
(adapted from Vidalain and others 2004).  
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In situ analysis reveals that PTP3 is a slightly acidic protein (pI 6.47) of ~136kDa with 
a large acidic core flanked by highly basic N- and C-terminal domains (Peuvel and others 
2002).  PTP3 is much larger than the other two known polar tube proteins and does not 
contain any cysteine residues.  Polyclonal antibodies generated against recombinant PTP3 
protein (amino acids 141-574) were used to confirm the location of the PTP3 protein 
(Peuvel and others 2002).  Immunofluorescence microscopy demonstrated that anti-rPTP3 
antibodies specifically react with the extruded polar tube of E. cuniculi (Figure 27).  In 
addition, immunoelectron microscopy demonstrated localization of PTP3 within cross-
sections of the E. cuniculi polar tube (Figure 27). 
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Peuvel and others found that addition of a thiol cleavable cross-linking agent, DSP, to 
crude extracts of E. cuniculi spores led to the precipitation of a large protein complex.  
Cleavage of the cross-links and separation of the proteins by SDS-PAGE revealed a pattern 
of five major protein bands.  PTP1 and PTP2 were the predominant components of the 
complex (Peuvel and others 2002).  The slowest migrating band was representative of PTP3.  
DSP mediated the formation of a large protein complex comprised of at least three proteins 
Figure 27 Localization of PTP3 within E. cuniculi. Immunolocalization of PTP3 using 
antibodies generated against recombinant PTP3 (amino acid 141-574). (A) An E. cuniculi 
spore (blue fluorescence) with its polar tube (green fluorescence) extruded was labeled 
with a 1:100 dilution of the anti-rPTP3 antibody (green fluorescence) and Uvitex 2B (blue 
fluorescence). (B) Dual immunolabeling using anti-rPTP3 with a TRITC-conjugated 
secondary antibody and a spore wall antiserum with a FITC-conjugated secondary 
antibody. The anti-rPTP3 antibody specifically reacts with the extruded polar tube (red 
fluorescence). (C-D) An E. cuniculi spore was labeled with anti-rPTP3 antibodies for 
immunoelectron microscopy. Notice the internal coiled polar tube (arrows). At a high 
magnification, the gold particles can be seen within the polar tube coils. The anti-rPTP3 
antibodies do not react with the spore wall (SW). (adapted from Peuvel and others 2002).      
B. A. 
C. D. 
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derived from the E. cuniculi polar tube and two unidentified proteins.  PTP3 lacks cysteine 
residues but is rich in charged residues and it has been suggested that PTP3 may interact 
with PTP1 and/or PTP2 via ionic bonds to aid in the formation of PTP1-PTP2 polymers during 
polar tube extrusion (Peuvel and others 2002).   
 To further characterize the potential interaction between MADAM and PTP3, 
additional yeast two-hybrid experiments were performed.  First, amino acids 141-574 of E. 
cuniculi PTP3 were introduced into the pGADT7-Rec vector by homologous recombination.  
Yeast transformed with the pGBKT7+MADAM (∆SS/∆TM) and the pGADT7-Rec+EcPTP3 
plasmids were screened for a potential interaction.  The yeast grew on SD/-Leu/-Trp medium 
indicating that the transformants contain the pGBKT7+MADAM (ΔSS/ΔTM) vector and the 
pGADT7-Rec+EcPTP3 vector.  In addition, several of the yeast transformants grew on TDO 
medium which indicates a potential positive interaction between the GAL4 DNA-BD+MADAM 
(ΔSS/ΔTM) fusion protein and the GAL4 AD+EcPTP3 fusion protein (Figure 28 and Figure 
29).  As expected, yeast transformed with only the pGADT7-Rec+EcPTP3 plasmid only grew 
on SD/-Leu medium (data not shown).  These initial yeast two-hybrid experiments indicate 
that MADAM has the ability to interact with PTP3 from E. cuniculi and E. intestinalis.    
To more specifically identify which MADAM domain or domains are responsible for 
the potential interaction with PTP3, several MADAM deletion mutants were generated and 
evaluated.  An overnight culture from each yeast colony was prepared and the OD600 of each 
culture was normalized prior to plating a dilution series on DDO, TDO, and QDO medium.  
Deletion of the unknown region alone (ΔSS/ΔUNK/ΔTM) or in combination with the 
disintegrin domain (ΔSS/ΔDIS/ΔUNK/ΔTM) did not appear to decrease the interaction 
between MADAM and EiPTP3 (Figure 30).  However, deletion of the disintegrin domain in 
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combination with the unknown region (MADAM ΔSS/ΔDIS/ΔUNK/ΔTM) did appear to slightly 
decrease the ability of MADAM to interact with EcPTP3 (Figure 29).  The ability of MADAM to 
interact with EcPTP3 and EiPTP3 was almost completely eliminated upon removal of the 
metalloprotease domain (ΔSS/ΔMET/ΔTM) from the MADAM construct (Figure 29 and 30).  
Our yeast two-hybrid analyses at least indirectly indicate that the interaction between 
MADAM and PTP3 relies on the MADAM metalloprotease domain.  Additional yeast two-
hybrid analyses should be conducted using a MADAM construct that consists of a mutated 
metalloprotease catalytic site instead of a complete deletion of the metalloprotease domain.  
Yeast two-hybrid screens were also performed to determine if MADAM interacts with 
either PTP1 or PTP2.  According to the yeast two-hybrid data, MADAM appears to interact 
with both EcPTP1 and EcPTP2 but does not interact with EcPTP2 as strongly as it does with 
EcPTP1 or EcPTP3 (Figure 28 and Figure 29).  Yeast transformants containing the pGADT7-
Rec+EcPTP2 and pGBKT7+MADAM (∆SS/∆TM) plasmids do not grow on the most stringent 
medium (QDO) whereas those with the pGADT7-Rec+EcPTP1 plasmid or pGADT7-
Rec+EcPTP3 plasmid do.  Interestingly, MADAM does not interact with EiPTP1 as strongly as 
it does with EiPTP2 or EiPTP3 (Figure 30). 
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 Figure 28 Yeast two-hybrid analysis of GAL4 DNA-BD+MADAM (∆SS/∆TM) and GAL4 AD+E. 
cuniculi polar tube protein 1, 2, and 3. First, the yeast were transformed with the vector to 
express the GAL4 DNA-BD+MADAM (∆SS/∆TM) fusion protein. The yeast were then 
transformed with vectors to express GAL4 AD-EcPTP1, EcPTP2, or EcPTP3 fusion proteins. 
A yeast colony representative of each transformant was re-streaked onto selective medium 
for evaluation of reporter gene expression. Growth of the yeast on SD/-Trp/-Leu medium 
indicates that both vectors are present. Growth of the yeast on SD/-Trp/-Leu/-His medium 
indicates that an interaction is occurring between the fusion proteins. A higher level of 
selection is provided by analyzing the yeast for growth on the SD/-Trp/-Leu/-His/-Ade 
medium. MADAM appears to interact with EcPTP1, EcPTP2, and EcPTP3 as evident by the 
growth of the yeast on the SD/-Trp/-Leu/-His medium. The interaction between MADAM 
and EcPTP1 and EcPTP3 is stronger than the interaction between MADAM and EcPTP2. 
Yeast expressing the GAL4 DNA-BD+MADAM (∆SS/∆TM) fusion protein and the GAL4 AD-
EcPTP2 fusion protein does not grow on the SD/-Trp/-Leu/-His/-Ade medium. 
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Figure 29 Yeast two-hybrid analysis of MADAM and the E. cuniculi polar tube proteins.  First, yeast were transformed with 
vectors to express various GAL4 DNA-BD+MADAM fusion proteins. The yeast were then transformed with vectors to express 
GAL4 AD-EcPTP1, EcPTP2, or EcPTP3 fusion proteins. Serial dilutions from normalized overnight yeast cultures were evaluated 
for growth on selective medium. Growth of the yeast on SD/-Trp/-Leu medium indicates that both vectors are present. Growth 
of the yeast on SD/-Trp/-Leu/-His medium indicates that an interaction is occurring between the fusion proteins. A higher level 
of selection is provided by analyzing the yeast for growth on the SD/-Trp/-Leu/-His/-Ade medium. MADAM appears to interact 
with EcPTP1, EcPTP2, and EcPTP3. The interaction between MADAM and EcPTP1 and EcPTP3 is stronger than the interaction 
between MADAM and EcPTP2. During preparation of the dilution series, the yeast colony expressing GAL4 DNA-BD+MADAM 
(ΔSS/ΔTM) and GAL4 AD+EcPTP2 did not grow as expected as evident by the lack of growth on SD/-Trp/-Leu medium. 
However, this yeast colony has been streaked onto selective medium and they grow well on SD/-Trp/-Leu and SD/-Trp/-Leu/-
His but not on SD/-Trp/-Leu/-His/-Ade (Figure 28). Evaluation of interactions between the MADAM deletion mutants and 
EcPTP3 revealed that removal of the metalloprotease domain was able to decrease the ability of the yeast to grow on the SD/-
Trp/-Leu/-His and SD/-Trp/-Leu/-His/-Ade.                    
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 79 
 
 
Figure 30 Yeast two-hybrid analysis of MADAM and the E. intestinalis polar tube proteins.  First, yeast were transformed with 
vectors to express various GAL4 DNA-BD+MADAM fusion proteins. The yeast were then transformed with vectors to express 
GAL4 AD-EiPTP1, EiPTP2, or EiPTP3 fusion proteins. Serial dilutions from normalized overnight yeast cultures were evaluated 
for growth on selective medium. Growth of the yeast on SD/-Trp/-Leu medium indicates that both vectors are present. Growth 
of the yeast on SD/-Trp/-Leu/-His medium indicates that an interaction is occurring between the fusion proteins. A higher level 
of selection is provided by analyzing the yeast for growth on the SD/-Trp/-Leu/-His/-Ade medium. MADAM appears to interact 
with EiPTP1, EiPTP2, and EiPTP3. The interaction between MADAM and EiPTP2 or MADAM and EiPTP3 is stronger than the 
interaction between MADAM and EiPTP1. Evaluation of interactions between the MADAM deletion mutants and EiPTP3 
revealed that removal of the disintegrin domain or unknown region does not appear to decrease the interaction between 
MADAM and EiPTP3. Unlike the interaction between MADAM and EcPTP3, removal of the metalloprotease domain only slightly 
decreased the interaction between MADAM and EiPTP3.  
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Confirmation of Yeast Two-Hybrid Interactions Using In Vitro Co-Immunoprecipitation  
In vitro co-immunoprecipitation is a popular technique used to confirm protein-
protein interactions initially identified during yeast two-hybrid screening.   In vitro 
transcription and translation procedures were performed using the pGBKT7+MADAM 
(ΔSS/ΔTM), pGADT7-Rec+EcPTP2, and pGADT7-Rec+EcPTP3 vectors to generate 35S-
labeled c-Myc+MADAM, HA+EcPTP2, and HA+EcPTP3 fusion proteins (Figure 31).  During 
the co-immunoprecipitation studies, HA-Tag Polyclonal Antibody was able to 
immunoprecipitate an EcPTP2-MADAM and an EcPTP3-MADAM complex (Figure 31).  We 
had anticipated that the interaction between MADAM and EcPTP2 may be too weak to 
detect by co-immunoprecipitation.         
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Figure 31 In vitro co-immunoprecipitation studies involving MADAM, EcPTP2, and EcPTP3. 
35S-labeled c-Myc+MADAM (Lane 1), HA+EcPTP2 (Lane 3), and HA+EcPTP3 (Lane 5) 
proteins were generated using the PROTEINSCRIPT® II in vitro transcription and translation 
protocol. c-Myc +MADAM and HA+EcPTP2 complexes (Lane 7) as well as c-Myc+MADAM and 
HA+EcPTP3 complexes (Lane 8) were immunoprecipitated in the presence of the anti-HA 
antibody. Each protein sample was separated by SDS-PAGE and analyzed by auto-
radiography. The c-Myc+MADAM protein should be ~59kDa. The HA+EcPTP2 protein should 
be ~35kDa. The HA+EcPTP3 protein should be ~51kDa. 
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CHAPTER 4 
CONCLUSIONS 
 
Since being recognized as a cause of chronic diarrhea in individuals infected with 
HIV, interest in microsporidia as human pathogens has grown.  Treatments options for 
human microsporidiosis are limited and there is a pressing need for continued research to 
develop better therapeutic strategies.  In addition to being pathogens of importance to 
human health, microsporidia also provide an opportunity to study the basic biology of highly 
specialized fungi.  A particularly fascinating characteristic of all microsporidia is the 
possession of a unique invasion apparatus known as the polar tube.  Traditionally, 
microsporidia were believed to infect host cells by extruding the polar tube at a velocity fast 
enough to pierce the host cell plasma membrane thereby allowing the infectious sporoplasm 
to pass through the hollow polar tube and into the host cell cytoplasm (Vivares and Metenier 
2001).  Many of the details regarding how polar tube extrusion leads to host cell infection 
are still undetermined.   
Microsporidia spore adherence to the host cell surface is hypothesized to be a 
prerequisite to polar tube extrusion and subsequent host cell infection.  Using an in vitro 
system E. intestinalis spores were shown to adhere to the host cell surface through at least 
one mechanism involving sulfated glycosaminoglycans (Hayman and others 2005).  
Numerous organisms including bacteria, viruses, and parasites exploit host cell 
glycosaminoglycans as adhesion receptors (Rostand and Esko 1997).  By manipulating host 
cell glycosaminoglycans during microsporidia spore adherence, we were able to 
demonstrate that a decrease in spore adherence led to a decrease in the occurrence of host 
cell infection (Hayman and others 2005).  These data represented the first evidence that 
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adherence of the microsporidia to the host cell surface directly correlates to host cell 
infection.        
Further examination of the factors involved in microsporidia spore adherence 
revealed a potential role of divalent cations, which are known effectors of numerous host-
pathogen interactions (Anzinger and others 2006; Southern and others 2006).  Addition of 
exogenous manganese and magnesium to the tissue culture medium resulted in an increase 
in adherence of E. cuniculi and E. intestinalis spores to the host cell monolayer and a 
subsequent increase in host cell infection (Southern and others 2006).  Interestingly, 
calcium did not contribute to an increase in microsporidia adherence but did lead to an 
increase in host cell infection (Southern and others 2006).  Calcium, which is known to play 
a role in the swelling of the polaroplast during polar tube extrusion, was hypothesized to 
increase the occurrence of polar tube extrusion and subsequent host cell infection in our in 
vitro system.  In support of this hypothesis, chelating agents were found to eliminate the 
augmentation of microsporidia spore adherence and host cell infection by the divalent 
cations (Southern and others 2006). 
  Like many other pathogenic intracellular organisms, microsporidia appear to use 
adherence to the host cell surface as a mechanism to facilitate infection.  To identify 
microsporidia proteins potentially involved in adherence, the E. cuniculi genome database 
was searched for genes that encode proteins with recognizable adhesion domains.  A 
protein (CAD25398) with sequence homology to members of the ADAM (a disintegrin and 
metalloprotease domain) family was found during this search.  ADAMs are a group of type I 
transmembrane glycoproteins involved in a variety of biological processes including cell 
adhesion, proteolysis, cell fusion, and signaling (White 2003).  Analysis of MADAM using the 
Conserved Domain Database revealed motifs in the sequence similar to those found in the 
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snake venom disintegrins (E-value = 4e-13) and zinc-dependent metalloproteases (E-value = 
1e-5), which includes the ADAM family (Marchler-Bauer and Bryant 2004).   
Most ADAMs share a common multi-domain organization consisting of a signal 
sequence, a pro-domain, a metalloprotease domain, a disintegrin-like domain, a cysteine-
rich domain, an epidermal growth factor (EGF)-like domain, and a transmembrane domain 
followed by a cytoplasmic tail (White 2003).  MADAM has a predicted signal sequence, pro-
domain, metalloprotease domain, disintegrin-like domain, and a transmembrane domain 
but lacks a recognizable cysteine-rich domain, EGF-like domain, and cytoplasmic tail.  In 
addition, MADAM contains a region of unknown homology located between the disintegrin 
and transmembrane domains.  Based on global pairwise alignment, MADAM appears to 
possess a conserved zinc-dependent catalytic site (HExxHxxGxxH) and ‘Met-Turn’.  Therefore, 
MADAM is predicted to be catalytically active.  Global pairwise alignment of the MADAM 
disintegrin domain with other ADAMs demonstrates that sequence identities range from 
33% for ADAM10 to 41% for ADAM9.  MADAM shares a high level of identity with other 
ADAMs due in part to the presence of fourteen conserved cysteine residues within its 
disintegrin domain.  MADAM also contains a five amino acid insertion (NIHKM) within the 
area considered to be the integrin-binding region of the disintegrin domain.  The significance 
of this amino acid insertion within the integrin-binding region remains to be determined.    
Consequently, the characterization of MADAM was obviously important because of its 
potential involvement in processes such as cell adhesion, proteolysis, cell fusion, and 
signaling.  Also, characterization of MADAM could provide the field of ADAM research with a 
unique representative from a fungal pathogen.  Our examination of MADAM was divided into 
three objectives.  First, we sought to determine the location of MADAM within the 
microsporidia spore.  Identification of MADAM on the spore surface or in the polar tube 
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would suggest that MADAM could facilitate events such as spore adherence or polar tube 
extrusion.  Second, we used an already established in vitro system to assay if MADAM is 
involved in spore adherence to the host cell and/or host cell infection.  Third, was the 
identification of potential substrates or binding partners for MADAM using yeast two-hybrid.  
By completing these objectives, we were able to provide an initial characterization of 
MADAM the protein.  
Immunoelectron microscopy was performed on E. cuniculi and E. intestinalis infected 
host cells using antibodies generated against the rMADAM-His·Tag protein.  Our data 
demonstrate that MADAM is localized to the polar sac-anchoring disk complex of mature E. 
cuniculi and E. intestinalis spores.  The polar sac-anchoring disk complex serves as an 
anchor between the polar tube and spore wall during polar tube extrusion.  In addition to 
being localized to the polar sac-anchoring disk complex, MADAM can be found in the 
exospore and plasma membrane of E. intestinalis spores.  In E. cuniculi, MADAM is only 
localized to the polar sac-anchoring disk complex.  The exospore is the electron-dense, 
surface exposed layer of the microsporidia spore wall (Wittner 1999).  In the spore wall, the 
plasma membrane lines the internal surface of the endospore (Wittner 1999).  A difference 
in MADAM localization between E. cuniculi and E. intestinalis was unexpected.  Originally E. 
intestinalis was classified as Septata intestinalis but was reclassified to the genus 
Encephalitozoon based on genetic and immunological studies (Hartskeerl and others 1995).  
The amount of sequence homology between MADAM from E. cuniculi and MADAM from is E. 
intestinalis is not known because the sequence for the E. intestinalis protein has not been 
determined.  MADAM does not represent the first protein to demonstrate variation among 
the species within the genus Encephalitozoon.  For example, spore wall protein 1 (SWP1) 
and spore wall protein 2 (SWP2) are both expressed in E. intestinalis but only SWP1 is 
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expressed in E. cuniculi and E. hellem (Hayman and others 2001).  Our demonstration that 
the expression pattern of MADAM differs between E. cuniculi and E. intestinalis may support 
the argument that E. intestinalis is unique within the genus (Hayman and others 2001).           
Closer examination of the immunoelectron microscopy data demonstrated that 
MADAM protein expression is developmentally or differentially regulated in E. intestinalis.  
Early during the process of merogony, MADAM expression occurs internally and on the 
periphery but continues to become more intense and delineated as the spores develop.  In 
some spores, MADAM expression occurs on the plasma membrane while in other spores 
expression occurs on the exospore.  Expression appears to be limited to one or the other 
location and rarely does MADAM localize to both the exospore and plasma membrane within 
the same spore.   
Localization of MADAM to different structures within E. intestinalis spores may be an 
indication of spore maturity.  Exospore localization occurs on spores that are forming an 
electron dense outer exospore layer.  Localization of MADAM to the plasma membrane 
appears to occur in spores without this electron dense exospore layer.  Alternatively, 
localization of MADAM to the exospore or plasma membrane may indicate differences in 
protein maturity.  MADAM localized to the plasma membrane may still possess the pro-
domain while localization to the exospore may indicate loss of the pro-domain and 
maturation of the MADAM protein.  Unfortunately, our attempt to generate antibodies 
specific for the MADAM pro-domain alone or the MADAM metalloprotease domain alone 
were unsuccessful.  The significance of MADAM protein expression patterns within E. 
intestinalis will be difficult to examine without the availability of a suitable system to 
genetically manipulate the microsporidia.   
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Localization of MADAM to the surface exposed exospore and within the polar sac-
anchoring disk complex of E. intestinalis indicates that MADAM could potentially be involved 
in adherence of the spore to the host cell and/or polar tube extrusion.  A series of in vitro 
assays were performed to determine if the rMADAM-His·Tag protein could be used to 
manipulate microsporidia spore adherence and/or host cell infection.  rMADAM-His·Tag 
protein was unable to significantly inhibit E. cuniculi spore adherence to the host cell 
monolayer.  This observation was not unexpected given that MADAM was not localized to the 
exospore of E. cuniculi.  rMADAM-His·Tag protein was able to decrease the occurrence of E. 
intestinalis spore adherence to the host cell monolayer by 50%-80%.  Addition of the rMET-
His·Tag or the rPRO-His·Tag protein to the spore adherence assay did not result in significant 
inhibition of E. intestinalis spore adherence.  This information indirectly indicates that the 
MADAM disintegrin domain may be involved in the process of spore adherence.  Attempts to 
recombinantly express the MADAM disintegrin domain alone for use in spore adherence 
assays were unsuccessful.        
Surprisingly, host cell infectivity assays revealed that the rMADAM-His·Tag protein was 
only able to decrease the occurrence of host cell infection by less than 20%.  This 
observation was unexpected given that the rMADAM-His·Tag protein decreased E. intestinalis 
spore adherence by 50%-80%.  As a control, spore adherence and host cell infectivity assays 
using CSA were included.  Addition of exogenous CSA resulted in at least a 40% decrease in 
E. intestinalis spore adherence and host cell infection.  We currently do not have an 
alternative method to examine and manipulate the process of spore adherence.  If a 
genetics system was available for microsporidia, we could suppress the expression of 
MADAM then examine the ability of the spores to adhere to the host cell surface and infect 
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the host cell.  Considering our current data, we cannot conclusively state that MADAM is 
involved in the process of spore adherence or host cell infection.        
As a protein sharing sequence homology with members of the ADAM family, it is 
possible that the MADAM protein has several functions.  To better understand what role 
MADAM serves, it is necessary to identify potential substrates or binding partners.  MADAM 
has the potential to interact with numerous host cell and/or microsporidia proteins.  A yeast 
two-hybrid approach was used to identify such protein-protein interactions involving MADAM.     
After evaluating the yeast two-hybrid data, we found E. intestinalis methionine 
aminopeptidase 2 (MetAP2) and E. intestinalis polar tube protein 3 (PTP3) to be the most 
interesting potential partners for the MADAM protein.  MetAP2 is an essential participant in 
the N-terminal methionine excision pathway and is responsible for post-translational 
modification of nascent proteins by removing the N-terminal methionine (Upadhya and 
others 2006).  Fumagillin, one of the therapies used for the treatment of human 
microsporidiosis, covalently binds to MetAP2 and specifically inhibits the peptidase activity.  
Although the potential interaction between MetAP2 and MADAM is worth characterizing 
further, we were more interested in investigating PTP3 protein for several reasons.  First, the 
PTP3 cDNA insert was positively identified from sequencing data from three separate 
colonies and several other colonies possessed cDNA inserts of the same size as the 
positively identified PTP3 cDNA inserts.  We assumed that these colonies also contain a 
PTP3 cDNA insert.  In addition, a potential interaction between MADAM and PTP3 seemed 
possible given that MADAM was localized to the polar sac-anchoring disk complex.   
In situ analysis reveals that PTP3 is a slightly acidic protein (pI 6.47) of ~136kDa with 
a large acidic core flanked by highly basic N- and C-terminal domains (Peuvel and others 
2002).  Addition of a cross-linking reagent to crude extracts of E. cuniculi spores led to the 
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formation of a large protein complex consisting of five major proteins (Peuvel and others 
2002).  PTP1 and PTP2 were the predominant components of the complex while the slowest 
migrating band was representative of PTP3 (Peuvel and others 2002).  PTP3 lacks cysteine 
residues but is rich in charged residues and it has been suggested that PTP3 may interact 
with PTP1 and/or PTP2 via ionic bonds to aid in the formation of PTP1-PTP2 polymers during 
polar tube extrusion (Peuvel and others 2002).  The two other proteins within the complex 
located at ~75kDa and ~28kDa remain to be identified.  In order to determine if the ~75kDa 
protein within the protein complex was MADAM, we attempted to duplicate the cross-linking 
experiment but were unsuccessful (data not shown).     
To further characterize the potential interaction between MADAM and PTP3, 
additional yeast two-hybrid experiments were performed.  First, we evaluated E. cuniculi 
PTP3 for an interaction with MADAM.  Our yeast two-hybrid experiments indicated that 
MADAM has the ability to interact with PTP3 from E. cuniculi and E. intestinalis.  To more 
specifically identify which MADAM domain or domains were responsible for the potential 
interaction with PTP3, several MADAM deletion mutants were generated and evaluated.  
Deletion of the unknown region alone or in combination with the disintegrin domain did not 
appear to decrease the interaction between MADAM and EiPTP3.  However, deletion of the 
disintegrin domain in combination with the unknown region did appear to slightly decrease 
the ability of MADAM to interact with EcPTP3.  The ability of MADAM to interact with EcPTP3 
and EiPTP3 was almost completely eliminated upon removal of the metalloprotease domain.  
Our yeast two-hybrid analyses at least indirectly indicate that the interaction between 
MADAM and PTP3 relies on the MADAM metalloprotease domain.  Further yeast two-hybrid 
experiments should be conducted using a MADAM construct that consists of a mutated 
metalloprotease catalytic site instead of a complete deletion of the metalloprotease domain.    
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Yeast two-hybrid screens were also performed to determine if MADAM interacts with 
either PTP1 or PTP2.  According to our yeast two-hybrid data, MADAM appears to interact 
with both EcPTP1 and EcPTP2 but does not interact with EcPTP2 as strongly as it does with 
EcPTP1 or EcPTP3.  Interestingly, MADAM does not interact with EiPTP1 as strongly as it 
does with EiPTP2 or EiPTP3.  PTP1 is a proline-rich acidic protein with a highly variable 
repeat-containing core while PTP2 is a lysine-rich basic protein with an acidic tail.  EcPTP1 
and EiPTP1 share 80% identity while EcPTP2 and EiPTP2 only share 49% homology.  Again, 
identification of different interactions involving MADAM from E. cuniculi versus E. intestinalis 
could be attributed to E. intestinalis being unique within the Encephalitozoon genus.  The 
interactions between EcPTP2-MADAM and EcPTP3-MADAM were confirmed by in vitro co-
immunoprecipitation. 
Future studies should include completion of our yeast two-hybrid screening and 
additional confirmation of potential protein interactions.  A major obstacle facing the 
characterization of interactions involving the MADAM protein is the lack of in vivo methods.  
As stated previously, a system to genetically manipulate microsporidia does not exist.  In 
addition, the examination of interactions involving native microsporidia proteins is 
challenging given that the proteins are most often isolated in the presence of high 
concentrations of an ionic detergent and reducing agent.   
Overall, our research has established a foundation for further characterization of the 
MADAM protein.  We demonstrated the location of MADAM within E. cuniculi and E. 
intestinalis spores.  We established that yeast two-hybrid analysis is a method suitable for 
the field of microsporidia research.  Finally, our preliminary yeast two-hybrid analyses 
indicate that MADAM may provide some function during polar tube extrusion through an 
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interaction involving the MADAM metalloprotease domain and components of the polar 
tube, specifically PTP3.   
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